Processing 00000000.tx.1: 1996 by The American Society for Biochemistry and Molecular Biology, Inc. 

Phrase: "1996 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."
Processing 00000000.tx.2: Regulation of Amyloid Protein Precursor (APP) Binding to Collagen and Mapping of the Binding Sites on APP and Collagen Type I (*) (Received for publication, September 7, 1995; and in revised form, November 2, 1995) Dirk Beher , Lars Hesse , Colin L. 

Phrase: "Regulation of Amyloid Protein Precursor (APP) Binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   851   C1655411:regulation of protein binding [Molecular Function]
   820   C1523122:regulation of binding [Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "to Collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "and"

Phrase: "Mapping of the Binding Sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1283195:Mapping [Activity]

Phrase: "on APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Collagen Type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "("

Phrase: "*"

Phrase: ")"

Phrase: "("

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "September 7,"

Phrase: "1995"

Phrase: ";"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "November 2,"

Phrase: "1995"

Phrase: ")"

Phrase: "Dirk Beher ,"

Phrase: "Lars Hesse ,"

Phrase: "Colin L."
Processing 00000000.tx.3: Masters (1), (2), Gerd Multhaup () From the (1)Center for Molecular Biology Heidelberg (ZMBH), University of Heidelberg, Im Neuenheimer Feld 282, D-69120 Heidelberg, Federal Republic of Germany Department of Pathology, University of Melbourne and the (2)Neuropathology Laboratory, Mental Health Research Institute of Victoria, Parkville, Victoria 3052, Australia ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS REFERENCES ABSTRACT The specific binding of the amyloid precursor protein (APP) to extracellular matrix molecules suggests that APP regulates cell interactions and has a function as a cell adhesion molecule and/or substrate adhesion molecule. 

Phrase: "Masters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "Gerd Multhaup"

Phrase: "("

Phrase: ")"

Phrase: "From the (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Center for Molecular Biology Heidelberg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   760   C0005532:Biology [Biomedical Occupation or Discipline]
   760   C0205099:Center [Spatial Concept]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "(ZMBH"

Phrase: ")"

Phrase: ","

Phrase: "University of Heidelberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Im Neuenheimer Feld 282,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3539078:IM [Idea or Concept]

Phrase: "D-"

Phrase: "69120 Heidelberg,"

Phrase: "Federal Republic of Germany Department of Pathology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   853   C0017482:Federal Republic of Germany [Geographic Area]

Phrase: "University of Melbourne"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "the (2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "Neuropathology Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Mental Health Research Institute of Victoria,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0025353:mental health [Mental Process]
   790   C0035172:Research Institute [Organization]
   790   C1555896:Mental Health [Intellectual Product]
   753   C0018684:Health [Idea or Concept]
   753   C0021622:institute [Organization]
   753   C0035168:research [Research Activity]
   753   C0229992:mental [Mental Process]
   753   C0242481:Research [Research Activity]
   753   C1272753:Institute [Idea or Concept]
   742   C0033876:Psychic Research [Research Activity]

Phrase: "Parkville,"

Phrase: "Victoria 3052,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042645:Victoria [Geographic Area]
   861   C0997115:Victoria [Plant]

Phrase: "Australia ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ABSTRACT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "The specific binding of the amyloid precursor protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0033618:Protein Binding [Molecular Function]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205369:Specific [Qualitative Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1552740:specific [Intellectual Product]

Phrase: "(APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "to extracellular matrix molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "regulates"

Phrase: "cell interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007582:Interactions, Cell [Cell Function]
   827   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "has"

Phrase: "a function as a cell adhesion molecule"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0007613:Cell Function [Cell Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
   738   C1148560:molecular function [Molecular Function]

Phrase: "and/or"

Phrase: "substrate adhesion molecule."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:Molecule [Substance]
   827   C1710236:Substrate [Manufactured Object]
   755 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.4: On the molecular level APP has binding sites for collagen, laminin, and glycosaminoglycans which is a characteristic feature of cell adhesion molecules. 

Phrase: "On the molecular level APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "has"

Phrase: "binding sites for collagen,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0005456:Binding Sites [Receptor]
   819   C1149167:collagen binding [Molecular Function]
   799 E C0682969:Binding Site [Amino Acid Sequence]
   770   C0205145:Sites [Spatial Concept]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "glycosaminoglycans"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017973:Glycosaminoglycans [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   966 E C3536869:Glycosaminoglycan [Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "a characteristic feature of cell adhesion molecules."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1562749:Cell feature [Organism Attribute]
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.5: We have examined the interactions between the APP and collagen types I and IV and identified the corresponding binding sites on APP and collagen type I. 

Phrase: "We"

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the interactions between the APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0872079:interactions protein [Molecular Function]
   714   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "collagen types I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   988   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   988   C1167375:collagen type I [Cell Component]
   884   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IV"

Phrase: "and"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the corresponding binding sites on APP"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0005456:Binding Sites [Receptor]
   767   C0033618:Protein Binding [Molecular Function]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205145:Sites [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   737 E C0682969:Binding Site [Amino Acid Sequence]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "collagen type I."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]
Processing 00000000.tx.6: We show that APP bound most efficiently to collagen type I in a concentration-dependent and specific manner in the native and heat-denatured states, suggesting an involvement of a contiguous binding site on collagen. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "most efficiently to collagen type I"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1167375:collagen type I [Cell Component]
   790   C0441729:Type I [Classification]
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C0021966:I- [Inorganic Chemical]
   753   C0205393:Most [Quantitative Concept]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0332307:Type [Qualitative Concept]
   753   C1167364:collagen [Cell Component]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "in a concentration-dependent"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0086045:Concentration [Mental Process]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1446561:Concentration [Quantitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "specific manner in the native"

Phrase: "and"

Phrase: "heat-denatured states,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1301808:states [Geographic Area]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an involvement of a contiguous binding site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C0449683:Site of involvement [Spatial Concept]
   748   C1314939:Involvement [Functional Concept]

Phrase: "on collagen."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]
Processing 00000000.tx.7: This binding site was identified on the cyanogen bromide fragment 1(I)CB6 of collagen type I, which also binds heparin. 

Phrase: "This binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0005456:Binding Site [Receptor]
  1000   C0682969:Binding Site [Amino Acid Sequence]
   861   C0205145:Site [Spatial Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "identified on the cyanogen bromide fragment 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0010511:Cyanogen Bromide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   748   C0006222:Bromide [Inorganic Chemical]
   748   C0056658:cyanogen [Hazardous or Poisonous Substance,Inorganic Chemical]
   748   C0205396:Identified [Qualitative Concept]
   748   C0332255:fragment [Functional Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "(I)CB6 of collagen type I,"

Phrase: "which also"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "heparin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.8: APP did not bind to collagen type I-heparin complexes, which suggests that there are overlapping binding sites for heparin and APP on collagen. 

Phrase: "APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to collagen type I-heparin complexes,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   814   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1167375:collagen type I [Cell Component]
   778   C0441729:Type I [Classification]
   757   C2245017:Complex I [Cell Component]
   748   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   748   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0332307:Type [Qualitative Concept]
   748   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C1145667:Bind [Activity]
   748   C1167364:collagen [Cell Component]
   748   C1167622:bind [Molecular Function]
   748   C1547052:*Type [Quantitative Concept]
   748   C1704241:Complexes [Chemical Viewed Structurally]
   714 E C0439855:Complex [Qualitative Concept]

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "overlapping binding sites for heparin"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0005456:Binding Sites [Receptor]
   797   C0456206:Overlapping sites [Spatial Concept]
   797   C1148608:Heparin Binding [Molecular Function]
   773 E C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Sites [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "APP on collagen."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   862   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   835 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   797   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.9: We localized the site of APP that mediates collagen binding within residues 448-465 of APP, which are encoded by the ubiquitously expressed APP exon 12, whereas the high affinity heparin binding site of APP is located in exon 9. 

Phrase: "We"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "the site of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "collagen binding within residues 448-465 of APP,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C1149167:collagen binding [Molecular Function]
   757   C0033618:Protein Binding [Molecular Function]
   757   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167364:collagen [Cell Component]
   739   C1167622:Binding [Molecular Function]

Phrase: "which"

Phrase: "are"

Phrase: "encoded by the ubiquitously expressed APP exon 12,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   782   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   775 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0679058:encoded [Mental Process]
   739   C1709634:Precursor [Idea or Concept]
   739   C2700640:Encoded [Activity]

Phrase: "whereas"

Phrase: "the high affinity heparin binding site of APP"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   777   C0054878:heparin-binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   777   C1332127:heparin-binding protein [Gene or Genome]
   760   C0005456:Binding Site [Receptor]
   760   C0682969:Binding Site [Amino Acid Sequence]
   760   C1148608:Heparin Binding [Molecular Function]
   760   C2945843:Site of [Qualitative Concept]
   757   C0033618:Protein Binding [Molecular Function]
   757   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205145:Site [Spatial Concept]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located in exon 9."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.10: Since a peptide encompassing this region binds to collagen type I and inhibits APP-collagen type I binding in nanomolar concentrations, this region may comprise the major part of the collagen type I binding site of APP. 

Phrase: "Since"

Phrase: "a peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "encompassing"

Phrase: "this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "binds to collagen type I"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1167375:collagen type I [Cell Component]
   806   C0441729:Type I [Classification]
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332307:Type [Qualitative Concept]
   760   C1145667:Bind [Activity]
   760   C1167364:collagen [Cell Component]
   760   C1167622:bind [Molecular Function]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "APP-collagen type I binding in nanomolar concentrations,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0033618:Protein Binding [Molecular Function]
   757   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1149167:collagen binding [Molecular Function]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]

Phrase: "this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "may"

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the major part of the collagen type I binding site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1292711:Part of [Spatial Concept]
   739   C0449719:Part [Spatial Concept]
   739   C1709471:Part [Quantitative Concept]

Phrase: "of APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.11: Moreover, our data also indicate that the collagen binding site is involved in APP-APP interaction that can be modulated by Zn(II) and heparin. 

Phrase: "Moreover,"

Phrase: "our data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the collagen binding site"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   901   C1149167:collagen binding [Molecular Function]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167364:collagen [Cell Component]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "is"

Phrase: "involved in APP-APP interaction"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   781   C0872079:Protein-Protein Interaction [Molecular Function]
           interaction protein
   781 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1314939:Involved [Functional Concept]
   742   C1704675:Interaction [Functional Concept]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "modulated by Zn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443264:Modulated [Spatial Concept]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "heparin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.12: Taken together, the data suggest that the regulation of APP binding to collagen type I by heparin occurs through the competitive binding of heparin and APP to collagen. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the regulation of APP binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   831   C1655411:regulation of protein binding [Molecular Function]
   804   C1523122:regulation of binding [Molecular Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "to collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "by heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "occurs through the competitive binding of heparin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0005458:Binding, Competitive [Molecular Function]
   774   C1148608:Heparin Binding [Molecular Function]
   748   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0243122:binding [Functional Concept]
   748   C0679932:competitive [Social Behavior]
   748   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "APP to collagen."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   862   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   835 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   797   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.13: INTRODUCTION The amyloid precursor protein (APP) ()belongs to a gene family in which three genes are known. 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "The amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "("

Phrase: ")"

Phrase: "belongs to a gene family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1517488:Gene Family [Gene or Genome]
   760   C0015576:Family [Family Group]
   760   C0017337:Gene [Gene or Genome]
   760   C1704727:Family [Conceptual Entity]

Phrase: "in which three genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.14: In addition to the APP gene, the genes for the amyloid precursor-related proteins APLP1 and APLP2 map to the human chromosomes 19 (APLP1) (1) and 11 (APLP2)(2, 3) . APP is encoded by the APP gene on the long arm of human chromosome 21 and has attracted attention due to its involvement in the deposition of amyloid A4 protein in the brain of patients with familial and sporadic Alzheimer's disease and individuals with trisomy 21(4, 5) . The role of APP in the pathogenesis of Alzheimer's disease has been underscored by the discovery of mutations within the A4 or sequences flanking the A4(6, 7, 8) . All of the identified susceptibility genes linked to Alzheimer's disease appear to influence the A4 amyloid formation(9, 10, 11) . From the high degree of evolutionary conservation of the endo- and ectodomain of APP and its widespread tissue expression, APP has been expected to be implicated in a variety of cellular processes and events. 

Phrase: "In addition to the APP gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]

Phrase: "the genes for the amyloid precursor-related proteins APLP1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0751455:genes proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C1412466:APLP1 gene [Gene or Genome]
   742   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "APLP2 map to the human chromosomes 19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0814036:chromosome map [Intellectual Product]
   748   C0024779:Map [Manufactured Object]
   748   C1706473:Map [Conceptual Entity]

Phrase: "(APLP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412466:APLP1 [Gene or Genome]

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "11"

Phrase: "(APLP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: ")"

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ") . APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "encoded by the APP gene"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   814   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   800 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0679058:encoded [Mental Process]
   748   C1709634:Precursor [Idea or Concept]
   748   C2700640:Encoded [Activity]

Phrase: "on the long arm"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0575519:Long arm [Finding]
   861   C0446516:Arm [Body Location or Region]
   861   C1269078:Arm [Body Part, Organ, or Organ Component]
   861   C1269612:Arm [Body Location or Region]
   805 E C0445456:Brachial [Spatial Concept]
   777 E C0206655:ARMS [Neoplastic Process]
   777 E C2681631:ARMS [Gene or Genome]

Phrase: "of human chromosome 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0008643:Human Chromosome [Cell Component]
   901   C0008664:Chromosome 21 [Cell Component]
   827   C0008633:Chromosome [Cell Component]

Phrase: "and"

Phrase: "has"

Phrase: "attracted attention due to its involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0004268:Attention [Mental Process]

Phrase: "in the deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "of amyloid A4 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:familial [Family Group]
  1000   C0241888:Familial [Functional Concept]
   928 E C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "sporadic Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "individuals with trisomy 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ") ."

Phrase: "The role of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "underscored by the discovery of mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0026882:Mutations [Genetic Function]
   753   C1880355:Discovery [Activity]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "within the A4"

Phrase: "or"

Phrase: "sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the A4"

Phrase: "(6,"

Phrase: "7,"

Phrase: "8"

Phrase: ") ."

Phrase: "All of the identified susceptibility genes"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   773   C0919453:Susceptibility Gene [Gene or Genome]
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0017337:Genes [Gene or Genome]
   753   C0205396:Identified [Qualitative Concept]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C0444868:All [Quantitative Concept]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C3539085:All [Idea or Concept]

Phrase: "linked to Alzheimer's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "the A4 amyloid formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "(9,"

Phrase: "10,"

Phrase: "11"

Phrase: ") ."

Phrase: "From the high degree"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0441889:Degree [Qualitative Concept]
   861   C0449286:Degree [Quantitative Concept]
   861   C0542560:Degree [Intellectual Product]
   861   C1561545:degree [Quantitative Concept]
   861   C2348088:Degree [Quantitative Concept]

Phrase: "of evolutionary conservation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347858:Conservation [Qualitative Concept]

Phrase: "of the endo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014175:Endo [Disease or Syndrome]
  1000   C1427293:ENDO [Gene or Genome]

Phrase: "and"

Phrase: "ectodomain of APP"

Phrase: "and"

Phrase: "its widespread tissue expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "implicated in a variety of cellular processes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C0007613:Cellular Process [Cell Function]
   762   C1325880:cellular process [Cell Function]
   748   C0007634:Cellular [Cell]
   748   C0178539:Cellular [Functional Concept]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]
   714   C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "events."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]
Processing 00000000.tx.15: Secreted isoforms of APP (APPs) containing a region homologous to the Kunitz protease inhibitor consensus sequence have a role in regulation of extracellular protease activity (12) and are endocytosed by the low density lipoprotein receptor-related protein(13) . A possible in vivo function is provided by the discovery that APP is a very potent inhibitor of factor XIa, and APP-factor XIa complexes might be involved in the regulation of the coagulation cascade(14, 15) . Another possible function of the ectodomain of secreted or membrane-associated forms of APP have also been shown to be involved in neuronal-cell or cell-matrix interactions and cell growth regulation (16, 17, 18, 19) . Here, the ability of APP to stimulate cell adhesion and growth does not depend on the Kunitz protease inhibitor domain but may derive from its high affinities for heparin, heparan sulfate proteoglycans, laminin, and collagen type IV(19, 20, 21, 22, 23, 24, 25, 26) . APP has been shown to bind Zn(II) and Cu(II) at two distinct sites (27, 28) and was recently found to belong to a family of zinc-modulated, heparin-binding proteins(29) . Zn(II) binding was shown to strengthen the binding of APP to heparin, thus demonstrating an interaction of residues involved in ligand binding which are located in different domains(21, 27) . Binding of metallic cations like Zn(II) and Cu(II) may control APP conformation and stability (27, 28, 30) and thus may promote the binding of APP to extracellular matrix elements like heparan sulfate proteoglycans(30) . We report here the regulation of APP binding to collagen type I by heparin and the mapping of the binding sites for APP to collagen type I and vice versa. 

Phrase: "Secreted isoforms of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: "(APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "homologous to the Kunitz protease inhibitor consensus sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0162774:Sequence, Homologous [Molecular Sequence]
   744   C1334043:Homologous [Gene or Genome]

Phrase: "have"

Phrase: "a role in regulation of extracellular protease activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "(12"

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "endocytosed by the low density lipoprotein receptor-related protein"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   818   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   818   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   790   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   764   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C0242972:low protein [Therapeutic or Preventive Procedure]
   762   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   762   C0599283:receptor density [Genetic Function]
   762   C0748025:low protein [Finding]
   742   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0178587:density [Quantitative Concept]
   742   C0205251:low [Qualitative Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1299352:Low [Qualitative Concept]
   742   C1550472:low [Idea or Concept]
   708   C0014139:endocytose [Cell Function]
   708 E C0163712:Relate [Organic Chemical]

Phrase: "(13"

Phrase: ") ."

Phrase: "A possible in vivo function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "provided by the discovery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1880355:Discovery [Activity]
   770   C1999230:Provided [Activity]

Phrase: "that APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "a very potent inhibitor of factor XIa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "APP-factor XIa complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   859   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   859   C1523872:protein complex [Cell Component]
   799   C1704241:Complexes [Chemical Viewed Structurally]
   766 E C0439855:Complex [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "involved in the regulation of the coagulation cascade"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C1326954:regulation of coagulation [Physiologic Function]
   744   C0005778:Coagulation [Organ or Tissue Function]
   744   C0441509:Coagulation [Therapeutic or Preventive Procedure]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1314939:Involved [Functional Concept]
   744   C1327622:Regulation [Biologic Function]
   744   C1328723:coagulation [Physiologic Function]
   744   C1707310:Cascade [Manufactured Object]

Phrase: "(14,"

Phrase: "15"

Phrase: ") ."

Phrase: "Another possible function of the ectodomain of secreted"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "or"

Phrase: "membrane-associated forms of APP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in neuronal-cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1269647:Cell [Cell]
   770   C1314939:Involved [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cell-matrix interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0007582:Interactions, Cell [Cell Function]
   793   C1704675:Interaction [Functional Concept]
   734   C1383501:Cell Matrix [Cell Component]

Phrase: "and"

Phrase: "cell growth regulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0596286:Cell Growth Regulation [Cell Function]
   901   C1160191:growth regulation [Organism Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0007595:Cell Growth [Cell Function]

Phrase: "(16,"

Phrase: "17,"

Phrase: "18,"

Phrase: "19"

Phrase: ") . Here,"

Phrase: "the ability of APP to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "stimulate"

Phrase: "cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "depend on the Kunitz protease inhibitor domain"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   778   C3536890:Protease Inhibitor [Pharmacologic Substance]
   774   C1514524:Protease Domain [Amino Acid Sequence]
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0725813:depend [Medical Device]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C1947941:Protease [Enzyme]
   748   C1999216:Inhibitor [Qualitative Concept]
   748   C3541951:Domain [Intellectual Product]

Phrase: "but"

Phrase: "may"

Phrase: "derive from its high affinities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for heparin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "heparan sulfate proteoglycans,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0062503:Heparan Sulfate Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1419892:HEPARAN SULFATE PROTEOGLYCAN [Gene or Genome]
   901   C0019143:Heparan Sulfate [Biologically Active Substance,Carbohydrate]
   827   C0033692:Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0038720:Sulfate [Inorganic Chemical]
   827   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   827   C2327880:Heparan [Biologically Active Substance]
   827   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "collagen type IV(19,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   923   C0009333:Collagen Type IV [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Collagen IV
   923   C1167363:collagen type IV [Cell Component]
   923   C3539839:Collagen Type IV [Laboratory Procedure]
   861   C0441732:Type IV [Classification]
   812   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   812   C0332307:Type [Qualitative Concept]
   812   C1167364:collagen [Cell Component]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0439689:Collagenous [Qualitative Concept]

Phrase: "20,"

Phrase: "21,"

Phrase: "22,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24,"

Phrase: "25,"

Phrase: "26"

Phrase: ") . APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Zn"

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "Cu(II"

Phrase: ")"

Phrase: "at two distinct sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "belong to a family of zinc-modulated, heparin-binding proteins"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   765   C0054878:heparin-binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   765   C1332127:heparin-binding protein [Gene or Genome]
   761   C0078803:zinc-binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1148608:Heparin Binding [Molecular Function]
   757   C1148621:zinc binding [Molecular Function]
   741 E C0033618:Protein Binding [Molecular Function]
   741   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   741   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0015576:Family [Family Group]
   739   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0243122:binding [Functional Concept]
   739   C0443264:Modulated [Spatial Concept]
   739   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1704727:Family [Conceptual Entity]
   739   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "(29"

Phrase: ") . Zn"

Phrase: "(II"

Phrase: ")"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "strengthen"

Phrase: "the binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to heparin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "thus"

Phrase: "demonstrating"

Phrase: "an interaction of residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "involved in ligand binding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1517880:Ligand Binding [Molecular Function]
   770   C0023688:Ligand [Chemical]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1314939:Involved [Functional Concept]

Phrase: "which"

Phrase: "are"

Phrase: "located in different domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1705242:Different [Qualitative Concept]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "(21,"

Phrase: "27"

Phrase: ") . Binding of metallic cations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1523815:cation binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "like Zn"

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "Cu(II"

Phrase: ")"

Phrase: "may"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "APP conformation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0033625:Protein Conformation [Spatial Concept]
   812   C0026377:Conformation [Spatial Concept]
   756   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "(27,"

Phrase: "28,"

Phrase: "30"

Phrase: ")"

Phrase: "and"

Phrase: "thus"

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to extracellular matrix elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "like heparan sulfate proteoglycans"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0062503:Heparan Sulfate Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1419892:HEPARAN SULFATE PROTEOGLYCAN [Gene or Genome]
   901   C0019143:Heparan Sulfate [Biologically Active Substance,Carbohydrate]
   827   C0033692:Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0038720:Sulfate [Inorganic Chemical]
   827   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   827   C2327880:Heparan [Biologically Active Substance]
   827   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "(30"

Phrase: ") ."

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "the regulation of APP binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   831   C1655411:regulation of protein binding [Molecular Function]
   804   C1523122:regulation of binding [Molecular Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "to collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "by heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "the mapping of the binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1283195:Mapping [Activity]

Phrase: "for APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "to collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "and"

Phrase: "vice versa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]
Processing 00000000.tx.16: Our binding studies reveal that APP binding to collagen type I is mediated by residues 448-465. 

Phrase: "Our binding studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that APP binding to collagen type I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0033618:Protein Binding [Molecular Function]
   762   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1149167:collagen binding [Molecular Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "mediated by residues 448-465."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.17: Since synthetic peptides representing this region show self-aggregational properties, it is suggested that APP-APP binding may exist. 

Phrase: "Since"

Phrase: "synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "self-aggregational properties,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]

Phrase: "it"

Phrase: "is"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that APP-APP binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   877   C0033618:Protein Binding [Molecular Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]

Phrase: "may"

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.18: APP was identified in the human platelet to be present in membrane associated and soluble forms (31) , and collagen is particularly important for initiation of platelet activation leading to successful formation of a hemostatic plug(32) . For this reason our findings suggest that APP as an adhesive glycoprotein may participate in collagen-induced platelet aggregation and as APPs may take part in the regulation of the coagulation cascade at sites of vascular injury. 

Phrase: "APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "identified in the human platelet to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0005821:Platelet [Cell]
   753   C0086418:Human [Human]
   753   C0205396:Identified [Qualitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "be"

Phrase: "present in membrane associated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "soluble forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "is"

Phrase: "particularly important for initiation of platelet activation"

Phrase: "leading to successful formation of a hemostatic plug"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   744   C0019116:Haemostatic [Organ or Tissue Function]
   744   C0019120:Haemostatic [Pharmacologic Substance]
   744   C0182324:Plug [Manufactured Object]
   744   C0220781:formation [Biologic Function]
   744   C0332152:Leading [Temporal Concept]
   744   C0439634:formation [Spatial Concept]
   744   C1272703:Successful [Qualitative Concept]
   744   C1522492:Formation [Functional Concept]
   744   C1522538:Leading [Functional Concept]
   744   C1705909:Plug [Medical Device]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(32"

Phrase: ") ."

Phrase: "For this reason"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that APP as an adhesive glycoprotein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   800   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   789 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   767   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "may"

Phrase: "participate in collagen-induced platelet aggregation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0369863:Collagen induced platelet aggregation [Clinical Attribute]
   833   C1268819:Induced platelet aggregation [Cell Function]
   790   C0032176:Platelet aggregation [Cell Function]
   790   C0677599:Platelet aggregation [Laboratory or Test Result]
   790   C0920267:Platelet Aggregation [Laboratory Procedure]
   753   C0005821:Platelet [Cell]
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C0205263:Induced [Functional Concept]
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
   753   C1167364:collagen [Cell Component]

Phrase: "and as APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   756   C3538722:APP [Laboratory Procedure]

Phrase: "may"

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "part in the regulation of the coagulation cascade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1292711:Part of [Spatial Concept]
   744   C0449719:Part [Spatial Concept]
   744   C1709471:Part [Quantitative Concept]

Phrase: "at sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "of vascular injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178324:Vascular injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.19: EXPERIMENTAL PROCEDURES MaterialsCollagen type I from bovine and human tissues (Sigma C-3511, C-7774) and collagen type IV (human placenta, Sigma C-7521) were used. 

Phrase: "EXPERIMENTAL PROCEDURES MaterialsCollagen type I from bovine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0441729:Type I [Classification]
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "human tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0440744:human tissues [Tissue]
   861   C0040300:Tissues [Tissue]
   861   C0086418:Human [Human]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "(Sigma C-3511,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1719918:Sigma [Intellectual Product]

Phrase: "C-7774"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "collagen type IV (human placenta,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0032043:Placenta [Embryonic Structure]
   804   C1278988:Placenta [Embryonic Structure]
   804   C1550656:Placenta [Body Substance]
   733 E C0230956:Placental [Mammal]
   717   C0009333:Collagen Type IV [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1167363:collagen type IV [Cell Component]
   717   C3539839:Collagen Type IV [Laboratory Procedure]

Phrase: "Sigma C-7521"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.20: Different collagen types were dissolved in 10 mM NaOAc, pH 5.5, and diluted with 10 mM Tris-HCl, pH 7.5, containing 100 mM NaCl, to appropriate concentrations just before use. 

Phrase: "Different collagen types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0332307:Types [Qualitative Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "dissolved in 10 mM NaOAc,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1549535:Dissolve [Functional Concept]

Phrase: "pH 5.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "diluted with 10 mM Tris-HCl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0814229:TRI [Intellectual Product]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "to appropriate concentrations just"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "before"

Phrase: "use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.21: Protein concentrations were determined by amino acid analysis. 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined by amino acid analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.22: Collagen type I was dissolved at 10 mg/ml in 70% formic acid, and solid CNBr (Merck) was added to a final concentration of 20 mg/ml. 

Phrase: "Collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "was"

Phrase: "dissolved at 10 mg/ml"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0439294:mg ml [Quantitative Concept]
   760   C0439269:mg% [Quantitative Concept]
   760   C0439526:/mL [Quantitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "in 70% formic acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0885348:formic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "solid CNBr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010511:CNBr [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Merck"

Phrase: ")"

Phrase: "was"

Phrase: "added to a final concentration of 20 mg/ml."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0439294:mg ml [Quantitative Concept]
   742   C0086045:Concentration [Mental Process]
   742   C0205088:Final [Temporal Concept]
   742   C0439269:mg% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1524062:Added [Functional Concept]
   742   C1546485:Final [Idea or Concept]
   742   C1960952:mg % [Quantitative Concept]
   742   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   708 E C1883712:Add [Functional Concept]
Processing 00000000.tx.23: Digestion was allowed to proceed for 18 h at 4 C. 

Phrase: "Digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "was"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "proceed for 18 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.24: Peptides were synthesized according to published methods (33) and purified on C-18 columns with a linear gradient of acetonitrile in 0.1% trifluoroacetic acid. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "synthesized according to published methods"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0034037:Published [Occupational Activity]
   760   C0449851:Methods [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C1704324:Published [Intellectual Product]
   760   C1883254:Synthesized [Activity]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "(33"

Phrase: ")"

Phrase: "and"

Phrase: "purified on C-18 columns"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1998793:Purified [Functional Concept]
   726   C1185738:Column [Body Part, Organ, or Organ Component]
   726   C1706132:Column [Idea or Concept]

Phrase: "with a linear gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]

Phrase: "of acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "in 0.1% trifluoroacetic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.25: Sequences were confirmed by amino acid sequence analysis (477A, Applied Biosystems). 

Phrase: "Sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "confirmed by amino acid sequence analysis"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   882   C0751970:Amino Acid Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0750484:Confirmed [Idea or Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1519249:Sequence [Functional Concept]
   753   C1524024:analysis [Functional Concept]
   719 E C1456348:Confirm [Qualitative Concept]

Phrase: "(477A,"

Phrase: "Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.26: Construction of Expression VectorsThe plasmid pFdIgA is based on the procaryotic expression vector pFdIgA(28) . For in vitro mutagenesis according to Kunkel(34) , M13mp18 replicative form DNA was cut with SalI-HindIII and religated in the presence of oligonucleotides TCGACCTGACTAGTTGCA and AGCTTGCAACTAGTCAGG to create a SpeI restriction site. 

Phrase: "Construction of Expression VectorsThe plasmid pFdIgA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "based on the procaryotic expression vector pFdIgA"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0442335:Vector [Spatial Concept]
   748   C1527178:Based [Functional Concept]
   748   C1705099:Vector [Idea or Concept]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(28"

Phrase: ") ."

Phrase: "For in vitro mutagenesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0079866:Mutagenesis [Molecular Function]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "according to Kunkel"

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "M13mp18 replicative form DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "cut with SalI-HindIII"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0000925:Cut [Injury or Poisoning]
   770   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "religated in the presence of oligonucleotides TCGACCTGACTAGTTGCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "AGCTTGCAACTAGTCAGG to"

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a SpeI restriction site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.27: A SacI-SpeI fragment of pFdIgA was cloned into M13mp18-SpeI, and the oligonucleotide CCCACATCTTCTGCAAATCACTATTATTTTTGATGATGAAC was annealed to the single-stranded DNA. 

Phrase: "A SacI-SpeI fragment of pFdIgA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cloned into M13mp18-SpeI,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0009013:cloned [Cell]
   737 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "the oligonucleotide CCCACATCTTCTGCAAATCACTATTATTTTTGATGATGAAC"

Phrase: "was"

Phrase: "annealed to the single-stranded DNA."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0012935:DNA, Single-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   754   C1979975:Single strand [Qualitative Concept]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
Processing 00000000.tx.28: The mutated sequence was exchanged with the corresponding fragment of pFdIgA (28) to construct the plasmid pFdIgA. 

Phrase: "The mutated sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "exchanged with the corresponding fragment of pFdIgA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]
   714   C0678640:exchange [Social Behavior]

Phrase: "(28"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "the plasmid pFdIgA."
Processing 00000000.tx.29: Purification of APPAPP was isolated from rat brain as described previously(21) . A full-length (Fd-APP) and truncated recombinant forms of human APP (Fd-APP, TP-APP) were prepared and purified in the form of a prokaryotic expressed Fd fusion protein by methods essentially as described by Weidemann et al.(35) . TP-APP represents the secreted form of APP (-secretase cleaved)(5) . After preparative SDS-PAGE and electroelution, the soluble protein was separated from salts and SDS by Excellulose GF-5 columns (Pierce). 

Phrase: "Purification of APPAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243114:purification [Functional Concept]
   790   C1998793:Purification [Functional Concept]

Phrase: "was"

Phrase: "isolated from rat brain"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(21"

Phrase: ") ."

Phrase: "A full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "(Fd-APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "truncated recombinant forms of human APP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "(Fd-APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "TP-APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "purified in the form of a prokaryotic expressed Fd fusion protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   754   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0332466:Fusion [Functional Concept]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C1293131:Fusion [Therapeutic or Preventive Procedure]
   738   C1522492:Form [Functional Concept]
   738   C1998793:Purified [Functional Concept]

Phrase: "by methods essentially"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "as"

Phrase: "described by Weidemann et al.(35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1552738:described [Idea or Concept]

Phrase: ") . TP-APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the secreted form of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "(-secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: ")"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ") ."

Phrase: "After preparative SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   827   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "electroelution,"

Phrase: "the soluble protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "separated from salts"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0036140:Salts [Chemical Viewed Structurally]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   756 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   756 E C0206136:Salt [Food,Inorganic Chemical]
   706 E C1537053:salty [Qualitative Concept]

Phrase: "and"

Phrase: "SDS by Excellulose GF-5 columns"

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.30: Protein concentrations were determined by amino acid analysis according to the manufacturer's protocol after hydrolysis with 6 N HCl, 0.1% phenol for 24 h at 110 C (420A Amino Acid Analysis System, Applied Biosystems). 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined by amino acid analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "according to the manufacturer's protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "after hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "with 6 N HCl,"

Phrase: "0.1% phenol for 24 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0070570:phenol [Organic Chemical,Pharmacologic Substance]

Phrase: "at 110 C (420A Amino Acid Analysis System,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   818   C0039152:analysis system [Occupational Activity]
   795   C0449913:System [Functional Concept]
   795   C1553451:System [Manufactured Object]
   795   C1704459:System [Medical Device]
   724 E C0205373:Systemic [Functional Concept]

Phrase: "Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.31: Binding Assay of Type I CollagenThe binding of proteins to collagen was determined by either dot blot or a solid-phase assay. 

Phrase: "Binding Assay of Type I CollagenThe binding of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0005507:Assay [Laboratory Procedure]
   742   C0243073:assay [Qualitative Concept]
   742   C1510438:Assay [Laboratory Procedure]

Phrase: "to collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "was"

Phrase: "determined by either dot blot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0013064:dot blot [Laboratory Procedure]
   760   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "a solid-phase assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.32: The dot blot assay was performed as described previously for APP-heparin binding(21) . The inhibitory effect of heparin was studied in the dot blot assay after preincubation of 3.5 pmol of I-rn-APP with 125 g/ml heparin in 1 PBS for 4 h at room temperature and separating the protein from salts and free heparin by Excellulose GF-5 columns (Pierce) and preincubation of dots coated with collagen in the presence of 40 g/ml heparin in 1 PBS for 1 h. 

Phrase: "The dot blot assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0013064:dot blot [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C0872145:DOT [Therapeutic or Preventive Procedure]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously for APP-heparin binding"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   814   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C0054878:heparin-binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1332127:heparin-binding protein [Gene or Genome]
   800 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C1148608:Heparin Binding [Molecular Function]
   778   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C0033618:Protein Binding [Molecular Function]
   774   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "(21"

Phrase: ") ."

Phrase: "The inhibitory effect of heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "studied in the dot blot assay"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0013064:dot blot [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0872145:DOT [Therapeutic or Preventive Procedure]
   753   C1510438:Assay [Laboratory Procedure]
   719   C0557651:Study [Manufactured Object]
   719   C2603343:Study [Research Activity]

Phrase: "after preincubation"

Phrase: "of 3.5 pmol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439192:pmol [Quantitative Concept]
   734   C0442758:3 5 [Quantitative Concept]

Phrase: "of I-rn-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with 125 g/ml heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in 1 PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "separating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:separating [Spatial Concept]

Phrase: "the protein from salts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "free heparin by Excellulose GF-5 columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "and"

Phrase: "preincubation of dots"

Phrase: "coated with collagen"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   790   C1167364:collagen [Cell Component]
   790   C1522408:Coated [Qualitative Concept]
   756 E C0453946:Coat [Manufactured Object]
   756 E C2987482:Coat [Body Part, Organ, or Organ Component]
   718 E C0439689:Collagenous [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 40 g/ml heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in 1 PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.33: After adsorption of collagen to microtiter wells, nonspecific binding sites were blocked by incubation for longer than 1 h with 1% BSA in PBS. 

Phrase: "After adsorption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001674:Adsorption [Laboratory Procedure]

Phrase: "of collagen to microtiter wells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0205170:Well [Qualitative Concept]
   779   C3146287:Well [Manufactured Object]

Phrase: "nonspecific binding sites"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0005456:Binding Sites [Receptor]
   896   C0457192:Nonspecific site [Body Location or Region]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "blocked by incubation"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "for longer"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]
   916 E C1444754:Length [Quantitative Concept]
   916 E C1706316:LENGTH [Research Activity]

Phrase: "than 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with 1% BSA"

Phrase: "in PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.34: I-Labeled proteins were diluted with PBS and added to the wells (1 10 to 2 10 cpm/well), together with the reagents to be tested. 

Phrase: "I-Labeled proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "diluted with PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "added to the wells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1524062:Added [Functional Concept]
   737   C0205170:Well [Qualitative Concept]
   737 E C1883712:Add [Functional Concept]
   737   C3146287:Well [Manufactured Object]

Phrase: "(1 10 to 2 10 cpm/well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0580272:1/2 [Intellectual Product]
   774   C1519043:1-2 [Research Activity]
   748   C0205170:Well [Qualitative Concept]
   748   C2827734:1+ [Quantitative Concept]
   748   C2981698:1+ [Classification]
   748   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "together with the reagents to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "be"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.35: After a 3-h incubation at room temperature, the wells were emptied. 

Phrase: "After a 3-h incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0041119:3 H [Element, Ion, or Isotope]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "the wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "emptied."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C1880497:Empty [Qualitative Concept]
   928 E C0333668:Depleted [Functional Concept]
   907 E C1550032:Unload [Idea or Concept]
   907 E C1996907:Emptying [Activity]
Processing 00000000.tx.36: The plate was divided into separate wells, and the radioactivity of bound ligand was measured by liquid scintillation counting. 

Phrase: "The plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "was"

Phrase: "divided into separate wells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332849:Divided [Functional Concept]
   770   C0443299:Separate [Spatial Concept]
   737   C0205170:Well [Qualitative Concept]
   737   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "the radioactivity of bound ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "measured by liquid scintillation counting."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0444706:Measured [Qualitative Concept]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C0750480:Count [Activity]
   726   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.37: The value obtained with wells coated with BSA was subtracted, as this represents nonspecific binding. 

Phrase: "The value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "obtained with wells"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C1301820:Obtained [Functional Concept]
   756   C0205170:Well [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   756   C3146287:Well [Manufactured Object]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "coated with BSA"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1522408:Coated [Qualitative Concept]
   756 E C0453946:Coat [Manufactured Object]
   756 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "subtracted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1719767:Subtract [Intellectual Product]
   966   C2348589:Subtract [Phenomenon or Process]

Phrase: ","

Phrase: "as"

Phrase: "this"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "nonspecific binding."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
Processing 00000000.tx.38: Results were expressed as the mean of duplicate determinations, which usually did not differ by more than 10%. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "expressed as the mean of duplicate determinations,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0205173:Duplicate [Functional Concept]
   748   C0444504:Mean [Quantitative Concept]
   748   C0680730:determinations [Governmental or Regulatory Activity]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]
   748   C3539942:Duplicate [Intellectual Product]
   714 E C1148554:determination [Laboratory Procedure]

Phrase: "which usually"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ by more"

Phrase: "than 10%."
Processing 00000000.tx.39: Determination of the Collagen Binding Domain of APPPurified rat brain APP and fusion proteins Fd-APP and Fd-APP were incubated at 37 C overnight with endoproteinase Lys-C (5 g) (Boehringer Mannheim). 

Phrase: "Determination of the Collagen Binding Domain of APPPurified rat brain APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "fusion proteins Fd-APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "Fd-APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "incubated at 37 C overnight"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439583:Overnight [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "with endoproteinase Lys-C (5 g) (Boehringer Mannheim"

Phrase: ")."
Processing 00000000.tx.40: After inactivating the protease for 1 min at 110 C, fragments were incubated in PBS overnight at room temperature with collagen type I bound to microtiter wells. 

Phrase: "After"

Phrase: "inactivating"

Phrase: "the protease for 1 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1947941:Protease [Enzyme]

Phrase: "at 110 C,"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "incubated in PBS overnight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439583:Overnight [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "to microtiter wells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205170:Well [Qualitative Concept]
   793   C3146287:Well [Manufactured Object]
Processing 00000000.tx.41: After being washed three times with cold PBS, bound peptides were extracted with formic acid. 

Phrase: "After"

Phrase: "being"

Phrase: "washed three times with cold PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "bound peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "extracted with formic acid."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0885348:formic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0202406:Acid [Laboratory Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]
Processing 00000000.tx.42: High performance liquid chromatography revealed one major fragment (16 kDa) in the eluate. 

Phrase: "High performance liquid chromatography"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
  1000   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
  1000   C1579831:High performance liquid chromatography [Functional Concept]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0597198:Performance [Individual Behavior]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C1882330:Performance [Activity]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "one major fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "(16 kDa) in the eluate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.43: The NH-terminal sequence was AAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVA, corresponding to residues 448-480 of APP. 

Phrase: "The NH-terminal sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "AAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVA,"

Phrase: "corresponding to residues 448-480 of APP."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   781 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.44: Similar digestions of I-rn-APP generated the same sized fragment as visualized by SDS-PAGE and autoradiography. 

Phrase: "Similar digestions of I-rn-APP"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C1523943:Protein Digestions [Organism Function]
   750 E C2349986:Protein Digestion [Research Activity]
       E   Digestion
   744   C0012238:digestions [Organism Function]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "the same sized fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "as"

Phrase: "visualized by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0234621:Visualized [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "autoradiography."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.45: Synthetic peptides representing candidates for the collagen binding region on APP and control peptides were dissolved in 0.1 PBS and tested as competing ligands for I-APP-collagen type I (human placenta) binding. 

Phrase: "Synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "candidates for the collagen binding region"

Phrase: "on APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "control peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "dissolved in 0.1 PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "tested as competing ligands"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0023688:Ligands [Chemical]
   770   C0392366:tested [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "for I-APP-collagen type I"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   845   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C1167375:collagen type I [Cell Component]
   795   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   795   C0332307:Type [Qualitative Concept]
   795   C1167364:collagen [Cell Component]
   795   C1547052:*Type [Quantitative Concept]
   724 E C0439689:Collagenous [Qualitative Concept]

Phrase: "(human placenta"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0032043:Placenta [Embryonic Structure]
   861   C1278988:Placenta [Embryonic Structure]
   861   C1550656:Placenta [Body Substance]
   789 E C0230956:Placental [Mammal]

Phrase: ")"

Phrase: "binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]
Processing 00000000.tx.46: Collagen type I was dot-blotted in duplicate onto nitrocellulose (0.05-10 g) and nonspecific binding sites were blocked with 1% BSA in 1 PBS for 1 h at room temperature. 

Phrase: "Collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "was"

Phrase: "dot-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "blotted in duplicate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205173:Duplicate [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]

Phrase: "onto nitrocellulose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   916 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "(0.05-10 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "nonspecific binding sites"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0005456:Binding Sites [Receptor]
   896   C0457192:Nonspecific site [Body Location or Region]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "blocked with 1% BSA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "in 1 PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.47: The dot blot was cut into strips and incubated with I-APP together with and without competing peptides for 3 h at room temperature in 0.1 PBS. 

Phrase: "The dot blot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013064:dot blot [Laboratory Procedure]

Phrase: "was"

Phrase: "cut into strips"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0000925:Cut [Injury or Poisoning]
   790   C1321564:strips [Medical Device]
   790   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "incubated with I-APP"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   833   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   814 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0021966:I- [Inorganic Chemical]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "together with"

Phrase: "and without competing peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C1515981:And [Idea or Concept]

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "in 0.1 PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720830:PBS [Disease or Syndrome]
   827   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.48: After incubation the dot blot was washed one time with blocking buffer, and the dots were excised, placed in scintillant, and assayed by counting. 

Phrase: "After incubation"

Phrase: "the dot blot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013064:dot blot [Laboratory Procedure]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "one time with blocking buffer,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C3241998:one time [Intellectual Product]
   760   C0040223:Time [Temporal Concept]
   760   C0205447:One [Quantitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "the dots"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1720485:Dots [Finding]
   966 E C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "excised"

Phrase: ","

Phrase: "placed in scintillant,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "assayed by counting."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C0750480:Count [Activity]
   756   C1510438:Assay [Laboratory Procedure]
   756   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.49: Variations of this binding assay were occasionally used and are indicated in the text and figure legends. 

Phrase: "Variations of this binding assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variations [Qualitative Concept]

Phrase: "were"

Phrase: "occasionally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Occasionally [Temporal Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "are"

Phrase: "indicated in the text"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1444656:Indicated [Finding]
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]

Phrase: "and"

Phrase: "figure legends."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.50: Determination of the APP Binding Domain of CollagenIn order to separate chains 1(I) and 2(I) of collagen type I, 2-3 mg of protein was heat-denatured and loaded onto 6% SDS-polyacrylamide gels (1(I)CB6 fragment: 15% polyacrylamide gel). 

Phrase: "Determination of the APP Binding Domain of CollagenIn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1148554:determination [Laboratory Procedure]

Phrase: "order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "chains 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]

Phrase: "(I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(I) of collagen type I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   900   C0009331:Collagen Type I I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1167375:collagen type I [Cell Component]

Phrase: "2-3 mg of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2346927:Mg+2 [Element, Ion, or Isotope,Pharmacologic Substance]
           Mg++
   760   C0439269:mg% [Quantitative Concept]
   760   C1960952:mg % [Quantitative Concept]

Phrase: "was"

Phrase: "heat-denatured"

Phrase: "and"

Phrase: "loaded onto 6% SDS-polyacrylamide gels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1708715:Loaded [Activity]
   719 E C1382104:Gel [Substance]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(I)CB6 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ":"

Phrase: "15% polyacrylamide gel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ")."
Processing 00000000.tx.51: Protein was electroeluted and extensively dialyzed against 1 HEPES buffered saline (10 mM HEPES, 150 mM NaCl, 0.005% Nonidet P-40, pH 7.4) to remove the SDS, followed by dialysis against 0.1 M acetic acid. 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "electroeluted"

Phrase: "and"

Phrase: "extensively"

Phrase: "dialyzed against 1 HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "buffered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "saline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036082:Saline [Substance]

Phrase: "(10 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.005% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the SDS,"

Phrase: "followed by dialysis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0011945:Dialysis [Natural Phenomenon or Process]
   790   C0011946:dialysis [Therapeutic or Preventive Procedure]
   790   C0917873:dialysis [Therapeutic or Preventive Procedure]
   790   C1059964:Dialysis [Eukaryote]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "against 0.1 M acetic acid."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   840   C0000985:Acetic acid [Organic Chemical]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]
   804   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   748 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.52: Purity of each preparation was checked by reverse phase-high performance liquid chromatography (Aquapore RP-300, buffer A: 0.1% trifluoroacetic acid, buffer B: 0.098% trifluoroacetic acid in 70% CHCN, gradient from 0% buffer B to 100% buffer B in 60 min). 

Phrase: "Purity of each preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882508:Purity [Quantitative Concept]

Phrase: "was"

Phrase: "checked by reverse phase-high performance liquid chromatography"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   833   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   833   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   833   C1579831:High performance liquid chromatography [Functional Concept]
   819   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   793   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   770   C0008565:Liquid Chromatography [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C0205250:High [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0302908:Liquid [Substance]
   744   C0597198:Performance [Individual Behavior]
   744   C1283174:Checked [Activity]
   744   C1299351:High [Qualitative Concept]
   744   C1304698:Liquid [Finding]
   744   C1546699:Liquid NOS [Intellectual Product]
   744   C1555029:Reverse [Idea or Concept]
   744   C1561501:Liquid NOS [Substance]
   744   C1882330:Performance [Activity]
   744   C2700149:HIGH [Intellectual Product]

Phrase: "(Aquapore RP-300,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1538326:RP [Gene or Genome]
   827   C3541325:RP [Idea or Concept]

Phrase: "buffer A"

Phrase: ":"

Phrase: "0.1% trifluoroacetic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "buffer B"

Phrase: ":"

Phrase: "0.098% trifluoroacetic acid in 70% CHCN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0040982:Trifluoroacetic Acid [Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]

Phrase: "gradient from 0% buffer B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]

Phrase: "to 100% buffer B"

Phrase: "in 60 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.53: CNBr cleavage of isolated chains was performed as described(36) . The identity of the 1(I)CB6 fragment has been confirmed by NH-terminal sequencing. 

Phrase: "CNBr cleavage of isolated chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(36"

Phrase: ") ."

Phrase: "The identity of the 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0424215:Identity [Mental Process]
   760   C2003939:Identity [Finding]

Phrase: "(I)CB6 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "confirmed by NH-terminal sequencing."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0205088:Terminal [Temporal Concept]
   760   C0268059:NH [Disease or Syndrome]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   726 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.54: APP Binding to the Synthetic Peptide CBP (Residues 448-480)A synthetic peptide corresponding to residues 448-480 of APP was adsorbed to microtiter wells (0.5-5 g/well) and incubated with 1% BSA in PBS for 1 h, I-labeled hs-APP was added (1 10 to 2 10 cpm/well) together with the competitors to be tested in PBS. 

Phrase: "APP Binding to the Synthetic Peptide CBP (Residues 448-480"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   751   C0033618:Protein Binding [Molecular Function]
   751   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1149098:peptide binding [Molecular Function]
   736   C0243122:binding [Functional Concept]
   736   C1145667:Binding [Activity]
   736   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "A synthetic peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "corresponding to residues 448-480 of APP"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   781 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "was"

Phrase: "adsorbed"

Phrase: "to microtiter wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205170:Well [Qualitative Concept]
   793   C3146287:Well [Manufactured Object]

Phrase: "(0.5-5 g/well"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "incubated with 1% BSA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "for 1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "I-labeled hs-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   799   C1709634:Precursor [Idea or Concept]
   709   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "(1 10 to 2 10 cpm/well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0580272:1/2 [Intellectual Product]
   774   C1519043:1-2 [Research Activity]
   748   C0205170:Well [Qualitative Concept]
   748   C2827734:1+ [Quantitative Concept]
   748   C2981698:1+ [Classification]
   748   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: "together with the competitors to"

Phrase: "be"

Phrase: "tested in PBS."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0392366:tested [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]
Processing 00000000.tx.55: After a 3-h incubation at room temperature the wells were emptied, dried, cut, and subjected to liquid scintillation counting. 

Phrase: "After a 3-h incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0041119:3 H [Element, Ion, or Isotope]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "the wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "emptied"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C1880497:Empty [Qualitative Concept]
   928 E C0333668:Depleted [Functional Concept]
   907 E C1550032:Unload [Idea or Concept]
   907 E C1996907:Emptying [Activity]

Phrase: ","

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: ","

Phrase: "cut,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "subjected to liquid scintillation counting."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726   C0681850:Subject [Group]
   726   C0750480:Count [Activity]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1705566:Count [Quantitative Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.56: The mean of duplicate measurements is given which was corrected for nonspecific binding (BSA alone). 

Phrase: "The mean of duplicate measurements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444504:Mean [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]

Phrase: "is"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "which"

Phrase: "was"

Phrase: "corrected for nonspecific binding"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205202:Corrected [Qualitative Concept]
   770   C0205370:Non-specific [Qualitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C0750540:Nonspecific [Idea or Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737 E C2349182:Correct [Qualitative Concept]

Phrase: "(BSA"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ")."
Processing 00000000.tx.57: Adsorption of Protein to Microtiter WellsMicrotiter wells (Falcon, microtest III, 96 flatbottom wells, flexible) were coated with either 0.05-10 g of collagen/well or 1% BSA in 200 l of PBS by incubation at room temperature overnight. 

Phrase: "Adsorption of Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001674:Adsorption [Laboratory Procedure]

Phrase: "to Microtiter WellsMicrotiter wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205170:Well [Qualitative Concept]
   793   C3146287:Well [Manufactured Object]

Phrase: "(Falcon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325579:Falcon, NOS [Bird]

Phrase: "microtest III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "96 flatbottom wells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205170:Well [Qualitative Concept]
   793   C3146287:Well [Manufactured Object]

Phrase: "flexible"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443220:Flexible [Qualitative Concept]
   928 E C0242808:Flexibility [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "coated with either 0.05-10 g of collagen/well"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   739   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   739   C0205170:Well [Qualitative Concept]
   739   C0439267:g% [Quantitative Concept]
   739   C1167364:collagen [Cell Component]
   739   C1522408:Coated [Qualitative Concept]
   739   C3146287:Well [Manufactured Object]
   706 E C0453946:Coat [Manufactured Object]
   706 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "1% BSA in 200 l of PBS"

Phrase: "by incubation"

Phrase: "at room temperature overnight."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]
   827   C0439583:Overnight [Temporal Concept]
   827   C1547703:Room [Spatial Concept]
Processing 00000000.tx.58: After a brief rinse, nonspecific binding sites in the wells were blocked for 1 h with 200 l of 1% BSA in PBS. 

Phrase: "After a brief rinse,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1701810:Rinse [Functional Concept]
   861   C1882955:Rinse [Activity]

Phrase: "nonspecific binding sites in the wells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0005456:Binding Sites [Receptor]
   767   C0457192:Nonspecific site [Body Location or Region]
   756 E C0682969:Binding Site [Amino Acid Sequence]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "blocked for 1 h"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0028778:Blocked [Pathologic Function]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332206:Blocked [Functional Concept]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "with 200 l"

Phrase: "of 1% BSA"

Phrase: "in PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.59: The wells were then rinsed with PBS and prepared for the appropriate assay. 

Phrase: "The wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed with PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "prepared for the appropriate assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]
   760   C1548787:Appropriate [Qualitative Concept]
   726   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.60: To determine the amount of collagen adsorbed to microtiter wells, 5 g of each collagen type were allowed to adsorb in microtiter wells overnight followed by a brief rinse. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the amount of collagen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "adsorbed"

Phrase: "to microtiter wells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205170:Well [Qualitative Concept]
   793   C3146287:Well [Manufactured Object]

Phrase: "5 g of each collagen type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "adsorb in microtiter wells overnight"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439583:Overnight [Temporal Concept]
   726   C0205170:Well [Qualitative Concept]
   726   C3146287:Well [Manufactured Object]

Phrase: "followed by a brief rinse."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1282927:brief [Qualitative Concept]
   760   C1701810:Rinse [Functional Concept]
   760   C1879313:Brief [Temporal Concept]
   760   C1882955:Rinse [Activity]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.61: Then protein was extracted from microtiter wells with three successive rinses of 100 l of formic acid and subjected to amino acid analysis after hydrolysis. 

Phrase: "Then protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "extracted from microtiter wells"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737   C0205170:Well [Qualitative Concept]
   737 E C2828366:Extract [Substance]
   737   C3146287:Well [Manufactured Object]

Phrase: "with three successive rinses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1701810:Rinse [Functional Concept]
   793   C1882955:Rinse [Activity]

Phrase: "of 100 l"

Phrase: "of formic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0885348:formic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "subjected to amino acid analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "after hydrolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020291:Hydrolysis [Natural Phenomenon or Process]
Processing 00000000.tx.62: The amount of protein adsorbed to the microtiter wells was quantified and calculated to be 50% of the amount of that was loaded. 

Phrase: "The amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "adsorbed to the microtiter wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0205170:Well [Qualitative Concept]
   726   C3146287:Well [Manufactured Object]

Phrase: "was"

Phrase: "quantified"

Phrase: "and"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "50% of the amount of that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "loaded."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.63: Ligand BlotProteins were denatured for 5 min in SDS-sample buffer, separated by SDS-PAGE, and transferred to nitrocellulose filters. 

Phrase: "Ligand BlotProteins"

Phrase: "were"

Phrase: "denatured for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "in SDS-sample buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "separated by SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose filters."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0180860:Filters [Manufactured Object]
   793 E C0581406:Filter [Medical Device]
   793 E C1522664:Filter [Intellectual Product]
   793 E C1704449:Filter [Conceptual Entity]
   793 E C1704684:Filter [Medical Device]
   793 E C1875155:FILTER [Medical Device]
Processing 00000000.tx.64: Nonspecific binding sites were blocked with 1% BSA in 1 PBS for 1 h at room temperature. 

Phrase: "Nonspecific binding sites"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0005456:Binding Sites [Receptor]
   896   C0457192:Nonspecific site [Body Location or Region]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "blocked with 1% BSA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "in 1 PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.65: Incubation was done either with I-APP (2 10 cpm/ml) or S-heparin (2.5 10 cpm/ml) in hypotonic binding buffer (14 mM NaCl, 0.27 mM KCl, 0.81 mM NaHPO 2HO, 0.15 mM KHPO) for 3 h at room temperature. 

Phrase: "Incubation"

Phrase: "was"

Phrase: "done"

Phrase: "either with I-APP"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   814 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0021966:I- [Inorganic Chemical]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "(2 10 cpm/ml) or S-heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   795   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(2.5 10 cpm/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C0653998:2-CPM [Organic Chemical,Pharmacologic Substance]

Phrase: "ml) in hypotonic binding buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "(14 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.27 mM KCl,"

Phrase: "0.81 mM NaHPO 2HO,"

Phrase: "0.15 mM KHPO"

Phrase: ")"

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.66: Filters were then washed three times for 5 min with binding buffer and exposed to Kodak XAR-5 films at -70 C. 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times for 5 min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with binding buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "exposed to Kodak XAR-5 films at -70 C."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   764   C0332157:Exposed to [Clinical Attribute]
           Exposed
   742   C0086296:Films [Manufactured Object]
   708 E C1561571:film [Biomedical or Dental Material]
   708 E C1561572:film [Substance]
Processing 00000000.tx.67: Iodination of APP105-kDa rat brain full-length APP was iodinated by the chloramine-T method (IODO-BEADS, Pierce) and separated from free iodine by heparin-Sepharose chromatography. 

Phrase: "Iodination of APP105-kDa rat brain full-length APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1159293:protein iodination [Molecular Function]
   738   C0430302:Iodination [Laboratory Procedure]
   738   C0542502:Iodination [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "iodinated by the chloramine-T method"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0055332:Chloramin T [Organic Chemical,Pharmacologic Substance]
   753   C0008164:Chloramine [Organic Chemical]
   753   C0025033:Chloramin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C0025663:Method [Intellectual Product]
   753   C0055330:chloramine [Inorganic Chemical]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "(IODO-BEADS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "Pierce"

Phrase: ")"

Phrase: "and"

Phrase: "separated from free iodine"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   819   C0369537:Iodine.free [Clinical Attribute]
   770   C0021966:Iodine- [Inorganic Chemical]
   770   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0086972:Separated [Finding]
   770   C0332296:free [Functional Concept]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C0885449:iodine [Pharmacologic Substance]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]
   770   C2348268:Iodine [Element, Ion, or Isotope]

Phrase: "by heparin-Sepharose chromatography."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0008552:Chromatography, Sepharose [Laboratory Procedure,Research Activity]
   827   C0008550:Chromatography [Laboratory Procedure]
   734   C0062515:heparin-sepharose [Carbohydrate,Pharmacologic Substance]
   727 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.68: RESULTS Characterization of Binding of APP to CollagenDuring our initial overlay studies using I-rn-APP to identify the cell surface receptor of APP that had earlier been proposed to exist(37) , we observed an APP-collagen interaction and decided to study this in more detail. 

Phrase: "RESULTS Characterization of Binding of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "to CollagenDuring"

Phrase: "our initial overlay studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "I-rn-APP to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "identify"

Phrase: "the cell surface receptor of APP"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   800   C0034800:Cell Surface Receptor [Amino Acid, Peptide, or Protein,Receptor]
   789   C0699040:Surface of cell [Cell Component]
           Cell surface
   770   C0007634:THE CELL [Cell]
           Cell
   767   C0018956:precursor cell [Cell]
   767   C0025252:protein surface [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   767   C1514760:Receptor Cell [Cell]
   744   C0205148:Surface [Spatial Concept]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "had"

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "an APP-collagen interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0872079:protein interaction [Molecular Function]
   804   C1704675:Interaction [Functional Concept]
   717   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "this in more detail."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1080058:This [Eukaryote]
   770   C1522508:Detail [Qualitative Concept]
   770   C1561567:detail [Functional Concept]
Processing 00000000.tx.69: First, we tested which different collagen types interact with APP. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "which different collagen types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0332307:Types [Qualitative Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "interact with APP."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   835 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.70: A dot blot assay revealed that I-labeled rn-APP binding to fibrillar collagen type I and basement membrane collagen type IV (38) was saturable and specific. 

Phrase: "A dot blot assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0013064:dot blot [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C0872145:DOT [Therapeutic or Preventive Procedure]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that I-labeled rn-APP binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   829   C0033618:Protein Binding [Molecular Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]

Phrase: "to fibrillar collagen type I"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   923   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1167375:collagen type I [Cell Component]
   861   C0441729:Type I [Classification]
   861   C0969669:Fibrillar Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1167374:fibrillar collagen [Cell Component]
   812   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0332307:Type [Qualitative Concept]
   812   C1167364:collagen [Cell Component]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0439689:Collagenous [Qualitative Concept]

Phrase: "and"

Phrase: "basement membrane collagen type IV (38"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   861   C0009333:Collagen Type IV [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Collagen IV
   861   C1167363:collagen type IV [Cell Component]
   861   C3539839:Collagen Type IV [Laboratory Procedure]
   827   C0004799:Basement membrane [Tissue]
   827   C0441732:Type IV [Classification]
   799   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   799   C0025255:Membrane [Tissue]
   799   C0332307:Type [Qualitative Concept]
   799   C0596901:Membrane [Cell Component]
   799   C1167364:collagen [Cell Component]
   799   C1547052:*Type [Quantitative Concept]
   799   C1706182:Membrane [Manufactured Object]
   799   C1979853:Basement [Cell Component]
   727 E C0205287:Membranous [Qualitative Concept]
   727 E C0439689:Collagenous [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "saturable"

Phrase: "and"

Phrase: "specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]
Processing 00000000.tx.71: APP bound most efficiently to collagen type I (data not shown). 

Phrase: "APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "most efficiently to collagen type I"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1167375:collagen type I [Cell Component]
   790   C0441729:Type I [Classification]
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C0021966:I- [Inorganic Chemical]
   753   C0205393:Most [Quantitative Concept]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0332307:Type [Qualitative Concept]
   753   C1167364:collagen [Cell Component]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.72: To investigate the kinetics of APP binding to collagen types I and IV and to gelatin in more detail, we used two distinct assays. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the kinetics of APP binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0022702:Kinetics [Natural Phenomenon or Process]
   748   C0220865:kinetics [Functional Concept]
   748   C2825046:Kinetics [Occupation or Discipline]

Phrase: "to collagen types I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   988   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   988   C1167375:collagen type I [Cell Component]
   884   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IV"

Phrase: "and to gelatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   790   C1145617:Gelatin [Food]
   790   C1515981:And [Idea or Concept]

Phrase: "in more detail,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1522508:Detail [Qualitative Concept]
   861   C1561567:detail [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two distinct assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.73: Radiolabeled rn-APP was incubated in microtiter wells with immobilized collagen types I and IV at room temperature in microtiter wells or BSA as a control. 

Phrase: "Radiolabeled rn-APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "incubated in microtiter wells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1439852:Incubated [Laboratory Procedure]
   737   C0205170:Well [Qualitative Concept]
   737   C3146287:Well [Manufactured Object]

Phrase: "with immobilized collagen types I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   912   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   912   C1167375:collagen type I [Cell Component]
   844   C0441729:Type I [Classification]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IV at room temperature"

Phrase: "in microtiter wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "or"

Phrase: "BSA as a control."
Processing 00000000.tx.74: APP-gelatin interaction was tested by incubating the protein with gelatin-Sepharose beads. 

Phrase: "APP-gelatin interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0872079:protein interaction [Molecular Function]
   804   C1704675:Interaction [Functional Concept]
   717   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "tested by incubating"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0392366:tested [Intellectual Product]
   790   C1439852:incubating [Laboratory Procedure]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "the protein with gelatin-Sepharose beads."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.75: The binding efficiency was observed to depend on salt concentration and showed substrate specificity (binding to collagens, but not to other extracellular matrix components, such as fibronectin or vitronectin). 

Phrase: "The binding efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "depend on salt concentration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0036140:Salt [Chemical Viewed Structurally]
   770   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0086045:Concentration [Mental Process]
   770   C0206136:Salt [Food,Inorganic Chemical]
   770   C0725813:depend [Medical Device]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "substrate specificity"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0038592:Substrate Specificity [Quantitative Concept]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   861   C1710236:Substrate [Manufactured Object]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "(binding to collagens,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C1149167:collagen binding [Molecular Function]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "but"

Phrase: "not to other extracellular matrix components,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0015350:Extracellular Matrix [Tissue]
   753   C0449432:Components [Manufactured Object]
   753   C0521119:Extracellular [Cell Component]
   753   C1518422:Not [Functional Concept]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "such as fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "vitronectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055023:Vitronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336937:VITRONECTIN [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.76: At the specific activity used, 10% of the I-labeled rn-APP added bound to collagen type I in a dot blot assay. 

Phrase: "At the specific activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0205369:Specific [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1552740:specific [Intellectual Product]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "10% of the I-labeled rn-APP"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   790   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   781 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0021966:I- [Inorganic Chemical]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1708632:Labeled [Qualitative Concept]
   742   C1709634:Precursor [Idea or Concept]
   742   C3540639:RN [Gene or Genome]
   708 E C0181496:Label [Manufactured Object]
   708 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "bound to collagen type I"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   862   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1167375:collagen type I [Cell Component]
   806   C0441729:Type I [Classification]
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332297:bound [Spatial Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C1145667:Bound [Activity]
   760   C1167364:collagen [Cell Component]
   760   C1167622:Bound [Molecular Function]
   760   C1547052:*Type [Quantitative Concept]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "in a dot blot assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0013064:dot blot [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C0872145:DOT [Therapeutic or Preventive Procedure]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.77: Binding was saturable and analyzed by using the methodology of Scatchard(39) . Assuming the presence of only one binding site on the collagen types I and IV, K values in the range of 0.5 10M for collagen type I (Fig.1), 4.5 10M for collagen type IV, and 1.5 10 for gelatin (data not shown) were calculated for the binding of APP to native and heat-denatured collagen (gelatin). 

Phrase: "Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "saturable"

Phrase: "and"

Phrase: "analyzed by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the methodology of Scatchard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0969625:methodology [Intellectual Product]
   770   C3266812:Methodology [Idea or Concept]

Phrase: "(39"

Phrase: ") ."

Phrase: "Assuming"

Phrase: "the presence of only one binding site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "on the collagen types I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   988   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   988   C1167375:collagen type I [Cell Component]
   884   C0441729:Type I [Classification]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IV,"

Phrase: "K values in the range of 0.5 10M"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   745   C1547411:Value range [Idea or Concept]
   742   C0042295:Values [Qualitative Concept]
   708 E C1522609:Value [Quantitative Concept]

Phrase: "for collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "(Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "4.5 10M for collagen type IV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1442446:10M [Temporal Concept]

Phrase: "and"

Phrase: "1.5 10 for gelatin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0450316:1/5 [Quantitative Concept]
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C1145617:Gelatin [Food]
   760   C2827734:1+ [Quantitative Concept]
   760   C2981698:1+ [Classification]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "calculated for the binding of APP"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   800   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   789 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0033618:Protein Binding [Molecular Function]
   767   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C0444686:Calculated [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "to native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302891:Native [Functional Concept]

Phrase: "and"

Phrase: "heat-denatured collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C1167364:collagen [Cell Component]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "(gelatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
  1000   C1145617:Gelatin [Food]

Phrase: ")."
Processing 00000000.tx.78: Figure 1: Binding curve of collagen type I with I-rn-APP. 

Phrase: "Figure 1"

Phrase: ":"

Phrase: "Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "curve of collagen type I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205134:Curve [Spatial Concept]

Phrase: "with I-rn-APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.79: The protein-coated wells were incubated with I-rn-APP at various concentrations. 

Phrase: "The protein-coated wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205170:Well [Qualitative Concept]
   793   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "incubated with I-rn-APP"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   814   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   800 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0021966:I- [Inorganic Chemical]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1709634:Precursor [Idea or Concept]
   748   C3540639:RN [Gene or Genome]

Phrase: "at various concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.80: The inset indicates the Scatchard plot for the binding curve. 

Phrase: "The inset"

Phrase: "indicates"

Phrase: "the Scatchard plot for the binding curve."
Processing 00000000.tx.81: Determination of the Collagen Binding Domain of APPTo map the putative and single collagen binding site, we used proteolytic fragments of purified fusion protein APP (Fd-APP) obtained by endoproteinase Lys-C digestion. 

Phrase: "Determination of the Collagen Binding Domain of APPTo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1148554:determination [Laboratory Procedure]

Phrase: "map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "the putative"

Phrase: "and"

Phrase: "single collagen binding site,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   861   C0005456:Binding Site [Receptor]
   861   C0682969:Binding Site [Amino Acid Sequence]
   861   C1149167:collagen binding [Molecular Function]
   812   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167364:collagen [Cell Component]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
   741 E C0439689:Collagenous [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "proteolytic fragments of purified fusion protein APP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   745   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   708 E C1708096:Fragment [Qualitative Concept]

Phrase: "(Fd-APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "obtained by endoproteinase Lys-C digestion."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0164055:endoproteinase Lys-C [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0012238:Digestion [Organism Function]
   753   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1301820:Obtained [Functional Concept]
   753   C2349986:Digestion [Research Activity]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.82: A mixture of fragments was incubated with collagen type I that had been immobilized to microtiter plates. 

Phrase: "A mixture of fragments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "incubated with collagen type I"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1167375:collagen type I [Cell Component]
   806   C0441729:Type I [Classification]
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332307:Type [Qualitative Concept]
   760   C1167364:collagen [Cell Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "immobilized"

Phrase: "to microtiter plates."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   867   C1709027:Microtiter Plate [Research Device]
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.83: Proteolytic fragments of APP that specifically bound to collagen type I were extracted from microtiter wells with formic acid. 

Phrase: "Proteolytic fragments of APP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "that specifically"

Phrase: "bound to collagen type I"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   862   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1167375:collagen type I [Cell Component]
   806   C0441729:Type I [Classification]
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332297:bound [Spatial Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C1145667:Bound [Activity]
   760   C1167364:collagen [Cell Component]
   760   C1167622:Bound [Molecular Function]
   760   C1547052:*Type [Quantitative Concept]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "were"

Phrase: "extracted from microtiter wells"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737   C0205170:Well [Qualitative Concept]
   737 E C2828366:Extract [Substance]
   737   C3146287:Well [Manufactured Object]

Phrase: "with formic acid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
  1000   C0885348:formic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.84: Amino acid sequence analysis of the only resulting fragment revealed the sequence to commence at residue 448 of APP (Fig.2). 

Phrase: "Amino acid sequence analysis of the only"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0751970:Amino Acid Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "resulting"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0678226:resulting [Functional Concept]
   966 E C1274040:Result [Functional Concept]
   966 E C1546471:Result [Idea or Concept]
   966 E C2825142:Result [Finding]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the sequence to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0004793:Sequence [Nucleotide Sequence]
   790   C0162326:Sequence [Nucleotide Sequence]
   790   C0162327:Sequence [Nucleotide Sequence]
   790   C1519249:Sequence [Functional Concept]
   718 E C1548958:Sequential [Idea or Concept]
   718 E C1705294:Sequential [Qualitative Concept]

Phrase: "commence at residue 448 of APP"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   800   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   789 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C1709915:Residue [Conceptual Entity]
   744   C1882936:RESIDUE [Phenomenon or Process]
   744   C3274784:Commence [Activity]

Phrase: "(Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.85: Other peaks were found to be caused by collagen (1 and 2 chains of collagen type I elute between 20 and 25 min, Fig.2) that was initially immobilized to the wells and was co-extracted with formic acid. 

Phrase: "Other peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:peaks [Quantitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "caused by collagen"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   790   C1167364:collagen [Cell Component]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   718 E C0439689:Collagenous [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2 chains of collagen type I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   809   C1292158:Type 2 chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0337112:chains [Manufactured Object]
   753   C1524075:Chains [Idea or Concept]

Phrase: "elute between 20"

Phrase: "and"

Phrase: "25 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "that"

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "immobilized to the wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0205170:Well [Qualitative Concept]
   737   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "was"

Phrase: "co-extracted with formic acid."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0885348:formic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]
Processing 00000000.tx.86: Figure 2: HPLC purification of a putative collagen binding peptide obtained by endoproteinase Lys-C digestion of Fd-APP encoded by exons 1-18 of APP (A) and Fd-APP encoded by exons 1-6 of APP (B). 

Phrase: "Figure 2"

Phrase: ":"

Phrase: "HPLC purification of a putative collagen binding peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243114:purification [Functional Concept]
   744   C1998793:Purification [Functional Concept]

Phrase: "obtained by endoproteinase Lys-C digestion of Fd-APP"
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   775   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   775   C0164055:endoproteinase Lys-C [Amino Acid, Peptide, or Protein,Enzyme]
   770 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   756   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1168438:Protein C [Laboratory Procedure]
   754   C1418943:PROTEIN C [Gene or Genome]
   754   C1523943:protein digestion [Organism Function]
   754   C2349986:Protein Digestion [Research Activity]
           Digestion
   754   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1168113:increased protein c [Finding]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0012238:Digestion [Organism Function]
   738   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1301820:Obtained [Functional Concept]
   738   C1709634:Precursor [Idea or Concept]
   704 E C1706701:Obtain [Activity]

Phrase: "encoded by exons 1-18 of APP"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   781 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0054966:Protein 18 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0679058:encoded [Mental Process]
   742   C1709634:Precursor [Idea or Concept]
   742   C2700640:Encoded [Activity]

Phrase: "(A)"

Phrase: "and"

Phrase: "Fd-APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "encoded by exons 1-6 of APP"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   781 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0679058:encoded [Mental Process]
   742   C1709634:Precursor [Idea or Concept]
   742   C2700640:Encoded [Activity]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.87: Only Fd-APP yielded the collagen binding peptide (black bar) determined by amino acid sequence analysis. 

Phrase: "Only Fd-APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "yielded"

Phrase: "the collagen binding peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   734   C1149167:collagen binding [Molecular Function]

Phrase: "(black bar)"

Phrase: "determined by amino acid sequence analysis."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   882   C0751970:Amino Acid Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1519249:Sequence [Functional Concept]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.88: Other fractions (hatched area) were revealed to contain collagen type I chains or fragments thereof. 

Phrase: "Other fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "(hatched area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "collagen type I chains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0337112:chains [Manufactured Object]
   812   C1524075:Chains [Idea or Concept]
   756   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1167375:collagen type I [Cell Component]

Phrase: "or"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "thereof."
Processing 00000000.tx.89: To confirm that we identified the collagen binding site of APP, three peptides of residues 448-465, 448-480, and 471-493 (Table1) were synthesized to perform inhibition studies. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the collagen binding site of APP,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0005456:Binding Site [Receptor]
   770   C0682969:Binding Site [Amino Acid Sequence]
   770   C1149167:collagen binding [Molecular Function]
   770   C2945843:Site of [Qualitative Concept]
   767   C0033618:Protein Binding [Molecular Function]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   744   C0205145:Site [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167364:collagen [Cell Component]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]

Phrase: "three peptides of residues 448-465,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "448-480,"

Phrase: "and"

Phrase: "471-493"

Phrase: "(Table1"

Phrase: ")"

Phrase: "were"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "inhibition studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.90: Two of these peptides were found to inhibit strongly the binding of I-hs-APP to collagen type I in a dot blot assay, with a calculated IC value of 150 nM (CBP1) and 75 nM (CBP) (Fig.3), whereas control peptides did not have any influence at concentrations of up to 20 g/ml. 

Phrase: "Two of these peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205448:Two [Quantitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "strongly"

Phrase: "the binding of I-hs-APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0033618:Protein Binding [Molecular Function]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "to collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "in a dot blot assay,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0013064:dot blot [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C0872145:DOT [Therapeutic or Preventive Procedure]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "with a calculated IC value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522609:Value [Quantitative Concept]

Phrase: "of 150 nM (CBP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1833097:CBP1 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "75 nM (CBP) (Fig.3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1328200:NM-3 [Pharmacologic Substance]
   804   C0312860:NM [Cell Function]
   804   C0349966:Fig [Food]
   804   C1337208:FIG [Food]
   804   C3539643:CBP [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "control peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any influence at concentrations of"

Phrase: "up to 20 g/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.91: As an independent control we used iodinated NCAM purified from rat brain according to Probstmeier et al. 

Phrase: "As an independent control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "iodinated NCAM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0282587:N-CAM [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1334863:NCAM [Gene or Genome]
   861   C1705802:NCAM [Gene or Genome]

Phrase: "purified from rat brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1998793:Purified [Functional Concept]

Phrase: "according to Probstmeier et al."
Processing 00000000.tx.92: (40) and did not observe any inhibition of NCAM binding to collagen in the presence of CBP concentrations of up to 5 g/ml (data not shown). 

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "any inhibition of NCAM binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C2259198:inhibition of binding [Molecular Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "to collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of CBP concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of"

Phrase: "up to 5 g/ml (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.93: Figure 3: Dose-dependent inhibition of the binding of I-hs-APP to collagen by the synthetic peptides CBP (diamonds), CBP1 (open squares), and CBP2 (filled squares). 

Phrase: "Figure 3"

Phrase: ":"

Phrase: "Dose-dependent inhibition of the binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C2259198:inhibition of binding [Molecular Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "of I-hs-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "by the synthetic peptides CBP (diamonds"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0057717:Diamonds [Element, Ion, or Isotope]
   779 E C1706341:Diamond [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "CBP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1833097:CBP1 [Gene or Genome]

Phrase: "(open squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "CBP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0625030:CBP2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413153:CBP2 [Gene or Genome]

Phrase: "(filled squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: The values represent residual binding determined in dependence of the concentration of the synthetic peptides as the competing ligands in a dot blot assay. 

Phrase: "The values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "residual binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "determined in dependence of the concentration of the synthetic peptides"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0011546:Dependence [Mental Process]
   739   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   739   C0086045:Concentration [Mental Process]
   739   C0439857:Dependence [Mental or Behavioral Dysfunction]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1883254:synthetic [Activity]
   739   C2698668:DEPENDENCE [Regulation or Law]
   726   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]

Phrase: "as the competing ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligands [Chemical]

Phrase: "in a dot blot assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0013064:dot blot [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C0872145:DOT [Therapeutic or Preventive Procedure]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.95: Since APP belongs to a superfamily, we further investigated synthetic peptides that represent homologous sequences of CBP in the APLP to inhibit APP binding to collagen type I. 

Phrase: "Since"

Phrase: "APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "belongs to a superfamily,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883220:Superfamily [Conceptual Entity]

Phrase: "we further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "that"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "homologous sequences of CBP"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0162774:Homologous Sequences [Molecular Sequence]
   770   C0162326:Sequences [Nucleotide Sequence]
   770   C1334043:Homologous [Gene or Genome]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "in the APLP to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412466:APLP [Gene or Genome]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "APP binding to collagen type I."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0033618:Protein Binding [Molecular Function]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1149167:collagen binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
Processing 00000000.tx.96: APP-collagen type I interaction could be less effectively inhibited by synthetic peptides of mouse APLP1 (residues 445-477) (1) and human ALPL2 (2, 3) (residues 522-554). 

Phrase: "APP-collagen type I interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   877   C0872079:protein interaction [Molecular Function]
   795   C1704675:Interaction [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "less effectively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]

Phrase: "inhibited by synthetic peptides of mouse APLP1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C1412466:APLP1 [Gene or Genome]
   748   C1883254:synthetic [Activity]
   745   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]

Phrase: "(residues 445-477"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "human ALPL2"

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "(residues 522-554"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.97: For both peptides, inhibition was found to be dose-dependent with an IC of about 1 M (5 g/ml) in a dot blot assay (data not shown). 

Phrase: "For both peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "dose-dependent with an IC of about 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1512045:Dose-dependent [Quantitative Concept]
   744   C0178602:Dose [Quantitative Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "M ("

Phrase: "5 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) in a dot blot assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.98: But mouse APLP1 and human APLP2 peptides (Table2) were still able to inhibit binding of APP to collagen type I although with a reduced capacity by a factor of 10. 

Phrase: "But"

Phrase: "mouse APLP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412466:APLP1 [Gene or Genome]

Phrase: "and"

Phrase: "human APLP2 peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(Table2"

Phrase: ")"

Phrase: "were"

Phrase: "still able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "although with a reduced capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Reduced [Qualitative Concept]
   760   C1516240:Capacity [Quantitative Concept]

Phrase: "by a factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "of 10."
Processing 00000000.tx.99: A possible explanation for this is given by the secondary structure prediction for CBP/hs-APP, CBP/mm-APLP1, and CBP/hs-APLP2 according to Chou and Fasman (Table3; (41) ) that changes from -structure for the NH terminus of CBP/APP to -structure in the same site of APLPs (Table3). 

Phrase: "A possible explanation for this"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "given by the secondary structure prediction"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0162807:Secondary Structure [Spatial Concept]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0678594:Structure [Spatial Concept]
   753   C0681842:Prediction [Idea or Concept]
   753   C1442162:GIVEN [Conceptual Entity]
   753   C1550718:given [Idea or Concept]
   753   C3244317:given [Intellectual Product]
   719 E C1947971:Give [Functional Concept]

Phrase: "for CBP/hs-APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "CBP/mm-APLP1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412466:APLP1 [Gene or Genome]

Phrase: "and"

Phrase: "CBP/hs-APLP2 according to Chou"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1412467:APLP2 [Gene or Genome]

Phrase: "and"

Phrase: "Fasman"

Phrase: "(Table3"

Phrase: ";"

Phrase: "(41"

Phrase: ")"

Phrase: ")"

Phrase: "that"

Phrase: "changes from -structure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C0678594:Structure [Spatial Concept]
   790   C1705241:Change [Quantitative Concept]

Phrase: "for the NH terminus"

Phrase: "of CBP/APP to -structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   858   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   799   C0678594:Structure [Spatial Concept]

Phrase: "in the same site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "of APLPs"

Phrase: "(Table3"

Phrase: ")."
Processing 00000000.tx.100: Furthermore, direct binding of peptides CBP and CBP1 to collagen type I was proven by surface plasmon resonance (BIAcore, Pharmacia Biotech Inc.). 

Phrase: "Furthermore,"

Phrase: "direct binding of peptides CBP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1149098:peptide binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "CBP1 to collagen type I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1833097:CBP1 [Gene or Genome]

Phrase: "was"

Phrase: "proven by surface plasmon resonance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0597731:Surface Plasmon Resonance [Molecular Biology Research Technique]
   760   C0205148:Surface [Spatial Concept]
   760   C0231881:Resonance [Finding]
   760   C0456369:Proven [Qualitative Concept]
   760   C0459800:resonance [Natural Phenomenon or Process]
   760   C0684213:Resonance [Qualitative Concept]

Phrase: "(BIAcore,"

Phrase: "Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.101: Collagen type I was immobilized to the dextran surface of the sensorchip(21) , but the kinetics of the binding reaction could not be determined, because two independent binding events, CBP to collagen and CBP to CBP, were observed to superimpose. 

Phrase: "Collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "was"

Phrase: "immobilized to the dextran surface of the sensorchip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]
   744   C0205148:Surface [Spatial Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the kinetics of the binding reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022702:Kinetics [Natural Phenomenon or Process]
   753   C0220865:kinetics [Functional Concept]
   753   C2825046:Kinetics [Occupation or Discipline]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "determined"

Phrase: ","

Phrase: "because"

Phrase: "two independent binding events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441471:Events [Event]
   812   C3541888:Events [Classification]

Phrase: "CBP to collagen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3539643:CBP [Gene or Genome]

Phrase: "and"

Phrase: "CBP to CBP,"

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "superimpose."
Processing 00000000.tx.102: This led us to the conclusion that both peptides showed a strong tendency for self-aggregation and suggested that CBP could represent a binding site for APP. 

Phrase: "This led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to the conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707478:Conclusion [Idea or Concept]

Phrase: "that"

Phrase: "both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a strong tendency for self-aggregation"

Phrase: "and"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that CBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539643:CBP [Gene or Genome]

Phrase: "could"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a binding site for APP."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0005456:Binding Site [Receptor]
   778   C0682969:Binding Site [Amino Acid Sequence]
   774   C0033618:Protein Binding [Molecular Function]
   774   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205145:Site [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
Processing 00000000.tx.103: If APP-APP binding could occur through the CBP sequence, APP should bind specifically to the synthetic peptide CBP. 

Phrase: "If"

Phrase: "APP-APP binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   877   C0033618:Protein Binding [Molecular Function]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]

Phrase: "could"

Phrase: "occur through the CBP sequence,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C3539643:CBP [Gene or Genome]

Phrase: "APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "should"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "specifically to the synthetic peptide CBP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1883254:synthetic [Activity]
   753   C3539643:CBP [Gene or Genome]
Processing 00000000.tx.104: The binding was analyzed in a solid-phase assay. 

Phrase: "The binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "analyzed in a solid-phase assay."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0205208:Solid [Qualitative Concept]
   753   C0205390:Phase [Temporal Concept]
   753   C0243073:assay [Qualitative Concept]
   753   C0302909:Solid [Substance]
   753   C0936012:Analyzed [Research Activity]
   753   C1378566:Solid [Biomedical or Dental Material]
   753   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.105: I-rn-APP was added to microtiter plates coated with the CBP in the absence or presence of Zn(II) and heparin. 

Phrase: "I-rn-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to microtiter plates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   867   C1709027:Microtiter Plate [Research Device]
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]

Phrase: "coated with the CBP"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1522408:Coated [Qualitative Concept]
   770   C3539643:CBP [Gene or Genome]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of Zn"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "heparin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.106: Binding of APP was found to be saturable and dependent of the amount of CBP coated to the microtiter plate (Fig.4A). 

Phrase: "Binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "saturable"

Phrase: "and"

Phrase: "dependent of the amount of CBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "coated to the microtiter plate"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C1709027:Microtiter Plate [Research Device]
   760   C0005971:Plate [Medical Device]
   760   C1139930:plate [Medical Device]
   760   C1522408:Coated [Qualitative Concept]
   760   C3537155:Plate [Manufactured Object]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.107: A dose-dependent inhibition of the binding of I-hs-APP to CBP by TP-APP was observed in nanomolar concentrations (Fig.4B). 

Phrase: "A dose-dependent inhibition of the binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C2259198:inhibition of binding [Molecular Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "of I-hs-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to CBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539643:CBP [Gene or Genome]

Phrase: "by TP-APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "observed in nanomolar concentrations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0086045:Concentrations [Mental Process]
   770   C0439282:nanomolar [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: Figure 4: Modulation of I-rn-APP binding to the CBP peptide. 

Phrase: "Figure 4"

Phrase: ":"

Phrase: "Modulation of I-rn-APP binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443264:Modulation [Spatial Concept]

Phrase: "to the CBP peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.109: No inhibitor (diamonds), heparin (open squares), and Zn(II) (filled triangles) were added at concentrations of 100 M ZnCl and 10 g/ml heparin. 

Phrase: "No inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(diamonds"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0057717:Diamonds [Element, Ion, or Isotope]
   966 E C1706341:Diamond [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(open squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Zn"

Phrase: "(II"

Phrase: ")"

Phrase: "(filled triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: "were"

Phrase: "added at concentrations of 100 M ZnCl"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0086045:Concentrations [Mental Process]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1524062:Added [Functional Concept]
   714 E C1446561:Concentration [Quantitative Concept]
   714 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "10 g/ml heparin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.110: APP binding to CBP was found to be inhibited by heparin and the divalent metal ions Zn(II) and Cu(II) in a concentration-dependent manner (A and C). 

Phrase: "APP binding to CBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "inhibited by heparin"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   790   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "and"

Phrase: "the divalent metal ions Zn"

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "Cu(II"

Phrase: ")"

Phrase: "in a concentration-dependent manner"

Phrase: "(A"

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.111: A dose-dependent inhibition of the binding of I-hs-APP to CBP by recombinant APP was observed in nanomolar concentrations (B). 

Phrase: "A dose-dependent inhibition of the binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C2259198:inhibition of binding [Molecular Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "of I-hs-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to CBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539643:CBP [Gene or Genome]

Phrase: "by recombinant APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]
   708   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "observed in nanomolar concentrations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0086045:Concentrations [Mental Process]
   770   C0439282:nanomolar [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.112: Inhibition of I-hs-APP binding to CBP yielded for instance 70% at 1 M Zn(II), 85% at 25 M, and 90% at 50 M Zn(II), but Ni(II), Co(II), and Fe(III) were unable to inhibit (C). 

Phrase: "Inhibition of I-hs-APP binding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   815   C2245433:inhibition of protein binding [Organism Function]
   793   C2259198:inhibition of binding [Molecular Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "to CBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539643:CBP [Gene or Genome]

Phrase: "yielded for instance 70% at 1 M Zn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1550608:Instance [Idea or Concept]

Phrase: "(II"

Phrase: ")"

Phrase: ","

Phrase: "85% at 25 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "90% at 50 M Zn"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C0441923:M+ [Intellectual Product]

Phrase: "(II"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "Ni(II"

Phrase: ")"

Phrase: ","

Phrase: "Co(II"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.113: The inhibition of binding was also found to be concentration-dependent for Zn(II) and Cu(II) but not for other divalent ions such as Fe(II), Co(II), and Ni(II) (Fig.4C). 

Phrase: "The inhibition of binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   909   C2259198:inhibition of binding [Molecular Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "concentration-dependent for Zn"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0086045:Concentration [Mental Process]
   770   C0851827:Dependent [Qualitative Concept]
   770   C1446561:Concentration [Quantitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "Cu(II"

Phrase: ")"

Phrase: "but"

Phrase: "not for other divalent ions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0022023:Ions [Element, Ion, or Isotope]
   760   C1518422:Not [Functional Concept]
   726 E C1700702:ION [Functional Concept]

Phrase: "such as Fe(II"

Phrase: ")"

Phrase: ","

Phrase: "Co(II"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Ni(II"

Phrase: ")"

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: Zinc(II) and copper(II) reduced binding to 10% (Zn(II)) and 20% (Cu(II)) at 50 M, 15% (Zn(II)) and 35% (Cu(II)) at 25 M, 30% (Zn(II)) and 50% (Cu(II)) at 1 M concentrations. 

Phrase: "Zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "(II"

Phrase: ")"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "binding to 10%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "(Zn"

Phrase: "(II"

Phrase: ")"

Phrase: ")"

Phrase: "and"

Phrase: "20%"

Phrase: "(Cu(II"

Phrase: ")"

Phrase: ")"

Phrase: "at 50 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "15%"

Phrase: "(Zn"

Phrase: "(II"

Phrase: ")"

Phrase: ")"

Phrase: "and"

Phrase: "35%"

Phrase: "(Cu(II"

Phrase: ")"

Phrase: ")"

Phrase: "at 25 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "30%"

Phrase: "(Zn"

Phrase: "(II"

Phrase: ")"

Phrase: ")"

Phrase: "and"

Phrase: "50%"

Phrase: "(Cu(II"

Phrase: ")"

Phrase: ")"

Phrase: "at 1 M concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.115: These values fall within the physiological Zn(II) and Cu(II) concentrations(42, 43) . When we tested the effect of Zn(II) (27, 30, 44) on binding of I-hs-APP to collagen type I, it did not have any effect on APP collagen type I binding up to concentrations of 100 M Zn(II) (data not shown), exceeding the saturating concentration of Zn(II) binding to APP(27) . Thus, under our experimental in vitro conditions, APP binding to collagen type I and CBP binding of APP are two mutually exclusive events of which only the binding of APP to CBP is regulated by the divalent metal ions Zn(II) and Cu(II) that both are ligands of APP(27, 28) . Since it has previously been reported that APP-collagen interaction is mediated by a heparin bridge mechanism(23) , we investigated APP collagen type I binding in the presence of heparin and chondroitin sulfate. 

Phrase: "These values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "fall within the physiological Zn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0085639:Fall [Finding]
   760   C0205463:Physiological [Functional Concept]
   760   C0238715:Fall [Temporal Concept]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "Cu(II"

Phrase: ")"

Phrase: "concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(42,"

Phrase: "43"

Phrase: ") ."

Phrase: "When"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the effect of Zn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(II"

Phrase: ")"

Phrase: "(27,"

Phrase: "30,"

Phrase: "44"

Phrase: ")"

Phrase: "on binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of I-hs-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to collagen type I,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any effect on APP collagen type I binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "up to concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 100 M Zn"

Phrase: "(II"

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "exceeding"

Phrase: "the saturating concentration of Zn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "(II"

Phrase: ")"

Phrase: "binding to APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "(27"

Phrase: ") . Thus,"

Phrase: "under our experimental in vitro conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "APP binding to collagen type I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0033618:Protein Binding [Molecular Function]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1149167:collagen binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "CBP binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "are"

Phrase: "two mutually exclusive events of which only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441471:Events [Event]
   748   C3541888:Events [Classification]

Phrase: "the binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to CBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539643:CBP [Gene or Genome]

Phrase: "is"

Phrase: "regulated by the divalent metal ions Zn"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0596455:divalent metal [Element, Ion, or Isotope]
   748   C0022023:Ions [Element, Ion, or Isotope]
   748   C0025552:Metal [Inorganic Chemical]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   714 E C1700702:ION [Functional Concept]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "Cu(II"

Phrase: ")"

Phrase: "that"

Phrase: "both"

Phrase: "are"

Phrase: "ligands of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023688:Ligands [Chemical]

Phrase: "(27,"

Phrase: "28"

Phrase: ") ."

Phrase: "Since"

Phrase: "it"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that APP-collagen interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0872079:protein interaction [Molecular Function]
   804   C1704675:Interaction [Functional Concept]
   717   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "mediated by a heparin bridge mechanism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0441712:Mechanism [Functional Concept]
   753   C0456378:Bridge [Medical Device]
   753   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "APP collagen type I binding in the presence of heparin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   766   C0054878:heparin-binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C1332127:heparin-binding protein [Gene or Genome]
   751   C0033618:Protein Binding [Molecular Function]
   751   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1148608:Heparin Binding [Molecular Function]
   751   C1149167:collagen binding [Molecular Function]
   736   C0243122:binding [Functional Concept]
   736   C1145667:Binding [Activity]
   736   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "chondroitin sulfate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008466:Chondroitin Sulfate [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0008454:Chondroitin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.116: APP Binding to Collagen Type I Is Inhibited by HeparinWhen collagen type I immobilized on plastic was incubated with I-APP together with increasing amounts of heparin or chondroitin sulfate, binding was inhibited in a concentration-dependent manner with an IC in the range of 0.1-1.0 g/ml (Fig.5). 

Phrase: "APP Binding to Collagen Type I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0033618:Protein Binding [Molecular Function]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1149167:collagen binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "Is"

Phrase: "Inhibited by HeparinWhen collagen type I"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1167375:collagen type I [Cell Component]
   790   C0441729:Type I [Classification]
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C1167364:collagen [Cell Component]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "immobilized on plastic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032167:Plastic [Substance]

Phrase: "was"

Phrase: "incubated with I-APP"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   833   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   814 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0021966:I- [Inorganic Chemical]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "together with increasing amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "chondroitin sulfate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008466:Chondroitin Sulfate [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0008454:Chondroitin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "inhibited in a concentration-dependent manner"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0086045:Concentration [Mental Process]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "with an IC"

Phrase: "in the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of 0.1-1.0 g/ml (Fig.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0349966:Fig [Food]
   793   C0439526:/mL [Quantitative Concept]
   793   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.117: Although both components are able to interact with glycosaminoglycans(45) , it was assumed that this effect was due to the binding of heparin and chondroitin sulfate to collagen type I (Table4), because chondroitin sulfate does not bind to APP (30) . Radioiodinated APP was saturated with heparin and separated from unbound, free heparin by desalting. 

Phrase: "Although"

Phrase: "both components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "interact with glycosaminoglycans"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0017973:Glycosaminoglycans [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   756 E C3536869:Glycosaminoglycan [Pharmacologic Substance]

Phrase: "(45"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "that"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was due to the binding of heparin"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0678226:Due to [Functional Concept]
           due
   774   C1148608:Heparin Binding [Molecular Function]
   748   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0043194:WAS [Disease or Syndrome]
   748   C0243122:binding [Functional Concept]
   748   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1421478:WAS [Gene or Genome]
   748   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "chondroitin sulfate to collagen type I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0008466:Chondroitin Sulfate [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0008454:Chondroitin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0038720:Sulfate [Inorganic Chemical]
   753   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   753   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "(Table4"

Phrase: ")"

Phrase: ","

Phrase: "because"

Phrase: "chondroitin sulfate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008466:Chondroitin Sulfate [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0008454:Chondroitin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to APP"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   835 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "(30"

Phrase: ") . Radioiodinated APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "saturated with heparin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0522534:Saturated [Phenomenon or Process]
   790   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C1705188:SATURATED [Quantitative Concept]

Phrase: "and"

Phrase: "separated from unbound, free heparin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0086972:Separated [Finding]
   760   C0332296:free [Functional Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "by desalting."
Processing 00000000.tx.118: It was found to bind to collagen type I, but collagen preincubated in a dot blot assay with heparin did not bind any longer to APP. 

Phrase: "It"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to collagen type I,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1167375:collagen type I [Cell Component]
   806   C0441729:Type I [Classification]
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332307:Type [Qualitative Concept]
   760   C1145667:Bind [Activity]
   760   C1167364:collagen [Cell Component]
   760   C1167622:bind [Molecular Function]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "but"

Phrase: "collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "preincubated in a dot blot assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0013064:dot blot [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0872145:DOT [Therapeutic or Preventive Procedure]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "with heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "any longer to APP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0205166:Long [Qualitative Concept]
   719   C1706317:Long [Qualitative Concept]
Processing 00000000.tx.119: In summary, these results show that heparin bound to collagen, but not bound to APP, inhibits the interaction between APP and collagen in a concentration-dependent manner (Table4, Fig.5). 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "bound to collagen,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167364:collagen [Cell Component]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
   718 E C0439689:Collagenous [Qualitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bound to APP,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   862   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   835 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0522527:Protein bound [Qualitative Concept]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332297:bound [Spatial Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1709634:Precursor [Idea or Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the interaction between APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0872079:interaction protein [Molecular Function]
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "collagen in a concentration-dependent manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C1167364:collagen [Cell Component]

Phrase: "(Table4,"

Phrase: "Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.120: Figure 5: Dose-dependent inhibition of the binding of I-rn-APP to collagen by heparin and chondroitin sulfate. 

Phrase: "Figure 5"

Phrase: ":"

Phrase: "Dose-dependent inhibition of the binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C2259198:inhibition of binding [Molecular Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "of I-rn-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "by heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "chondroitin sulfate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008466:Chondroitin Sulfate [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0008454:Chondroitin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.121: The binding to collagen type I immobilized on a microtiter well was determined in the presence of increasing concentrations of heparin and chondroitin sulfate and found to be concentration-dependent. 

Phrase: "The binding to collagen type I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1149167:collagen binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "immobilized on a microtiter well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]

Phrase: "was"

Phrase: "determined in the presence of increasing concentrations of heparin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0086045:Concentrations [Mental Process]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0442808:Increasing [Functional Concept]
   742   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "chondroitin sulfate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008466:Chondroitin Sulfate [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0008454:Chondroitin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "concentration-dependent."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0086045:Concentration [Mental Process]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1446561:Concentration [Quantitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.122: Determination of the APP Binding Domain of CollagenTo further examine this, we decided to investigate whether the high affinity heparin binding site of type I collagen that has been localized in the COOH-terminal CB fragment of the molecule (46) is the critical site responsible for the binding of APP to type I collagen. 

Phrase: "Determination of the APP Binding Domain of CollagenTo further"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1148554:determination [Laboratory Procedure]

Phrase: "examine"

Phrase: "this,"

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "the high affinity heparin binding site of type I collagen"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0005456:Binding Site [Receptor]
   760   C0682969:Binding Site [Amino Acid Sequence]
   760   C1148608:Heparin Binding [Molecular Function]
   760   C2945843:Site of [Qualitative Concept]
   757   C1149167:collagen binding [Molecular Function]
   739   C0205145:Site [Spatial Concept]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "localized in the COOH-terminal CB fragment of the molecule"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0205088:Terminal [Temporal Concept]
   739   C0332255:fragment [Functional Concept]
   739   C0392752:Localized [Spatial Concept]
   739   C0567416:Molecule [Substance]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "(46"

Phrase: ")"

Phrase: "is"

Phrase: "the critical site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "responsible for the binding of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "to type I collagen."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]
Processing 00000000.tx.123: We examined the abilities of collagen type I to bind heparin by affinity chromatography and performed binding studies with S-heparin and I-rn-APP. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the abilities of collagen type I to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Abilities [Organism Attribute]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "heparin by affinity chromatography"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "performed binding studies with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "S-"

Phrase: "heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "I-rn-APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.124: Since the binding of collagen to heparin-Sepharose is necessary but not sufficient to fulfil the criteria of heparin binding, CB fragments of collagen type I eluting at 600 mM NaCl from heparin-Sepharose were separated by SDS-PAGE, transferred to nitrocellulose filters, and incubated with S-heparin. 

Phrase: "Since"

Phrase: "the binding of collagen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1149167:collagen binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to heparin-Sepharose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0062515:heparin-sepharose [Carbohydrate,Pharmacologic Substance]
   861   C0036681:Sepharose [Carbohydrate]

Phrase: "is"

Phrase: "necessary"

Phrase: "but"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "fulfil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Fulfill [Idea or Concept]

Phrase: "the criteria of heparin binding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243161:criteria [Intellectual Product]

Phrase: "CB"

Phrase: "fragments of collagen type I eluting"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1167375:collagen type I [Cell Component]
   790   C0441729:Type I [Classification]
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0332255:fragment [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0486805:Fragments [Body Substance]
   753   C1167364:collagen [Cell Component]
   753   C1547052:*Type [Quantitative Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "at 600 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "from heparin-Sepharose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0062515:heparin-sepharose [Carbohydrate,Pharmacologic Substance]
   861   C0036681:Sepharose [Carbohydrate]

Phrase: "were"

Phrase: "separated by SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose filters,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0180860:Filters [Manufactured Object]
   793 E C0581406:Filter [Medical Device]
   793 E C1522664:Filter [Intellectual Product]
   793 E C1704449:Filter [Conceptual Entity]
   793 E C1704684:Filter [Medical Device]
   793 E C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "S-"

Phrase: "heparin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.125: Heparin binding was found in the covalently linked, partially digested dimers or trimers of the -chains, the 1(I)CB8 and the 1(I)CB6 fragments (Fig.6, A and B). 

Phrase: "Heparin binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1148608:Heparin Binding [Molecular Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "found in the covalently"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: ","

Phrase: "partially digested dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "or"

Phrase: "trimers of the -chains,"

Phrase: "the 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(I)CB8"

Phrase: "and"

Phrase: "the 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(I)CB6 fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "(Fig.6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.126: Figure 6: The 1(I)CB6 peptide binds S-heparin and I-rn-APP. 

Phrase: "Figure 6"

Phrase: ":"

Phrase: "The 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(I)CB6 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "S-"

Phrase: "heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "I-rn-APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.127: The resulting peptides of CNBr digestion of 1(I) and 2(I) chains were fractionated by heparin-Sepharose chromatography. 

Phrase: "The resulting peptides of CNBr digestion of 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(I) chains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]

Phrase: "were"

Phrase: "fractionated by heparin-Sepharose chromatography."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0008552:Chromatography, Sepharose [Laboratory Procedure,Research Activity]
   806   C0062515:heparin-sepharose [Carbohydrate,Pharmacologic Substance]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1979893:Fractionated [Qualitative Concept]
Processing 00000000.tx.128: Fractions eluting at 600 mM NaCl were analyzed by SDS-PAGE (gradient from 10 to 15% polyacrylamide) and stained with Coomassie (A) or incubated with S-heparin after blotting to nitrocellulose (B). 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "eluting at 600 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by SDS-PAGE (gradient"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1704732:Page [Intellectual Product]

Phrase: "from 10"

Phrase: "to 15% polyacrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]

Phrase: ")"

Phrase: "and"

Phrase: "stained with Coomassie"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(A)"

Phrase: "or"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "S-"

Phrase: "heparin after blotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "to nitrocellulose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   916 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.129: Partially digested dimers and trimers of the -chains, the 1(I)CB8, and the 1(I)CB6 fragment (arrow) bind S-heparin. 

Phrase: "Partially digested dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "trimers of the -chains,"

Phrase: "the 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(I)CB8,"

Phrase: "and"

Phrase: "the 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(I)CB6 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "S-"

Phrase: "heparin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.130: CNBr fragments of 1(I) and 2(I) chains were separated by SDS-PAGE and incubated with I-rn-APP after blotting to nitrocellulose. 

Phrase: "CNBr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010511:CNBr [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: "fragments of 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1708096:Fragment [Qualitative Concept]

Phrase: "(I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(I) chains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "incubated with I-rn-APP"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   814   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   800 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0021966:I- [Inorganic Chemical]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1709634:Precursor [Idea or Concept]
   748   C3540639:RN [Gene or Genome]

Phrase: "after blotting"

Phrase: "to nitrocellulose."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   916 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]
Processing 00000000.tx.131: Binding was found to the 1(I)CB6 fragment as the only CNBr fragment (C) indicated by the arrow. 

Phrase: "Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "found to the 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "(I)CB6 fragment as the only CNBr fragment"

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "indicated by the arrow."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.132: The asterisk indicates incompletely digested and/or covalently cross-linked dimers of the -chains. 

Phrase: "The asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "indicates"

Phrase: "incompletely"

Phrase: "digested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digested [Physiologic Function]

Phrase: "and/or"

Phrase: "covalently"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "dimers of the -chains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596448:dimers [Chemical Viewed Structurally]
Processing 00000000.tx.133: In an overlay assay I-rn-APP binding to collagen type I was observed to partially digested dimers or trimers of the -chains and to the 1(I)CB6 fragment as the only CNBr fragment showing up at an apparent molecular mass of 25 kDa (Fig.6C). 

Phrase: "In an overlay assay I-rn-APP binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   822   C0033618:Protein Binding [Molecular Function]
   793   C0243122:binding [Functional Concept]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]

Phrase: "to collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to partially digested dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "or"

Phrase: "trimers of the -chains"

Phrase: "and to the 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "(I)CB6 fragment as the only CNBr fragment showing"

Phrase: "up"

Phrase: "at an apparent molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "of 25 kDa (Fig.6C"

Phrase: ")."
Processing 00000000.tx.134: To determine the identity of this fragment, it was purified from SDS gels and characterized by amino acid sequence analysis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the identity of this fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0424215:Identity [Mental Process]
   760   C2003939:Identity [Finding]

Phrase: "it"

Phrase: "was"

Phrase: "purified from SDS gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017243:Gels [Biomedical or Dental Material]
   770   C1998793:Purified [Functional Concept]
   737 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "characterized by amino acid sequence analysis."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   882   C0751970:Amino Acid Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1519249:Sequence [Functional Concept]
   753   C1524024:analysis [Functional Concept]
   753   C1880022:Characterized [Activity]
Processing 00000000.tx.135: Higher bands represent uncomplete digested and/or covalently cross-linked dimers of the -chains. 

Phrase: "Higher bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "uncomplete"

Phrase: "digested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digested [Physiologic Function]

Phrase: "and/or"

Phrase: "covalently"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "dimers of the -chains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596448:dimers [Chemical Viewed Structurally]
Processing 00000000.tx.136: The results presented above show that the 1(I)CB6 fragment of collagen type I contains binding sites for both APP and the glycosaminoglycan heparin. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(I)CB6 fragment of collagen type I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "binding sites for both APP"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0005456:Binding Sites [Receptor]
   774   C0033618:Protein Binding [Molecular Function]
   774   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205145:Sites [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   745 E C0682969:Binding Site [Amino Acid Sequence]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "the glycosaminoglycan heparin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.137: Since it has been indicated that the triple helical structure of collagen is important for the interaction with heparin(46) , the 1 and 2 collagen chains and the CNBr fragment 1(I)CB6 were separated by SDS-PAGE, electroeluted, and assayed separately in a dot blot apparatus by incubation with I-rn-APP. 

Phrase: "Since"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the triple helical structure of collagen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "important for the interaction"

Phrase: "with heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "the 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2 collagen chains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337112:chains [Manufactured Object]
   827   C1524075:Chains [Idea or Concept]

Phrase: "and"

Phrase: "the CNBr fragment 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010511:CNBr [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "(I)CB6"

Phrase: "were"

Phrase: "separated by SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "electroeluted"

Phrase: ","

Phrase: "and"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "separately in a dot blot apparatus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013064:dot blot [Laboratory Procedure]
   753   C0243111:apparatus [Manufactured Object]
   753   C0872145:DOT [Therapeutic or Preventive Procedure]
   753   C1947951:Apparatus [Anatomical Structure]

Phrase: "by incubation"

Phrase: "with I-rn-APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.138: Binding was strongest to the 1 chain of collagen type I, less binding was observed to the 1CB6 fragment, and no specific binding could be observed to the 2 chain of collagen type I (Fig.7, A and B). 

Phrase: "Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "strongest to the 1 chain of collagen type I,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0442821:Strong [Qualitative Concept]

Phrase: "less binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "observed to the 1CB6 fragment,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332255:fragment [Functional Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "no specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "observed to the 2 chain of collagen type I"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1167375:collagen type I [Cell Component]
   784   C1292158:Type 2 chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C1440484:Collagen type 2 [Immunologic Factor]
   764   C0441729:Type I [Classification]
   762   C0441730:Type 2 [Classification]
   742   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   742   C0021966:I- [Inorganic Chemical]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0332307:Type [Qualitative Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C1167364:collagen [Cell Component]
   742   C1441672:Observed [Functional Concept]
   742   C1524075:Chain [Idea or Concept]
   742   C1547052:*Type [Quantitative Concept]

Phrase: "(Fig.7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.139: This result is consistent with binding studies for which I-rn-APP and gelatin-Sepharose affinity chromatography indicated that APP recognizes heat-denatured collagen as well as triple-helical fibrillar collagen. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "consistent with binding studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for which I-rn-APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   804   C1709634:Precursor [Idea or Concept]
   708   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "gelatin-Sepharose affinity chromatography"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C0008552:Chromatography, Sepharose [Laboratory Procedure,Research Activity]
   861   C0008551:Chromatography, Affinity [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C1510827:Affinity [Natural Phenomenon or Process]
   712 E C0302647:chromatograph [Medical Device]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "recognizes"

Phrase: "heat-denatured collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C1167364:collagen [Cell Component]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "as well as"

Phrase: "triple-helical fibrillar collagen."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0969669:Fibrillar Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1167374:fibrillar collagen [Cell Component]
   812   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   812   C1167364:collagen [Cell Component]
   741 E C0439689:Collagenous [Qualitative Concept]
Processing 00000000.tx.140: Apparently, the APP binding site in the 1CB6 fragment has less tight specificity, probably due to the change of conformation of surrounding residues. 

Phrase: "Apparently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "the APP binding site in the 1CB6 fragment"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0005456:Binding Site [Receptor]
   760   C0682969:Binding Site [Amino Acid Sequence]
   757   C0033618:Protein Binding [Molecular Function]
   757   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205145:Site [Spatial Concept]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]

Phrase: "has"

Phrase: "less tight specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "probably due to the change of conformation of surrounding residues."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C0678226:Due to [Functional Concept]
           due
   739   C0026377:Conformation [Spatial Concept]
   739   C0392747:Change [Functional Concept]
   739   C0443172:change [Quantitative Concept]
   739   C0750492:Probably [Idea or Concept]
   739   C1282914:Surrounding [Spatial Concept]
   739   C1705241:Change [Quantitative Concept]
   739   C3146286:Due [Idea or Concept]
   722   C0301641:Conformational change [Molecular Function]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.141: Figure 7: Binding of I-APP to collagen type I in a dot blot assay. 

Phrase: "Figure 7"

Phrase: ":"

Phrase: "Binding of I-APP"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   814 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C0033618:Protein Binding [Molecular Function]
   783   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0021966:I- [Inorganic Chemical]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0243122:binding [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "to collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "in a dot blot assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0013064:dot blot [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C0872145:DOT [Therapeutic or Preventive Procedure]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.142: No specific binding to the 2(I) chain of collagen could be observed (0% of total was specific) (A). 

Phrase: "No specific binding to the 2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C2610645:NO binding [Molecular Function]
   753   C0205369:Specific [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1552740:specific [Intellectual Product]

Phrase: "(I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "chain of collagen"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   790   C0337112:Chain [Manufactured Object]
   790   C1167364:collagen [Cell Component]
   790   C1524075:Chain [Idea or Concept]
   718 E C0439689:Collagenous [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(0% of total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439175:% total [Quantitative Concept]
   790   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.143: Saturable and specific binding was found to the 1(I) chain (54% of total was specific) (A), collagen type I (66% of total was specific), and the CNBr fragment 1(I)CB6 (70% of total was specific) (B). 

Phrase: "Saturable"

Phrase: "and"

Phrase: "specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "found to the 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "(I) chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "(54% of total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439175:% total [Quantitative Concept]
   790   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "(66% of total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439175:% total [Quantitative Concept]
   790   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the CNBr fragment 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010511:CNBr [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "(I)CB6"

Phrase: "(70% of total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439175:% total [Quantitative Concept]
   790   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.144: The total amount of protein immobilized to nitrocellulose was determined by amino acid analysis. 

Phrase: "The total amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "immobilized"

Phrase: "to nitrocellulose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "was"

Phrase: "determined by amino acid analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.145: Numbering of cyanogen bromide peptides (CB) of the 1 chain of collagen type I according to Miller et al.(71) and Piez et al.(72) . In conclusion, our observations reveal a mechanism of APP binding to collagen that is regulated by glycosaminoglycans that compete with APP for an overlapping binding site of the 1 CB6 fragment of collagen. 

Phrase: "Numbering of cyanogen bromide peptides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449788:numbering [Quantitative Concept]
   726 E C0237753:*Number [Quantitative Concept]

Phrase: "(CB) of the 1 chain of collagen type I"

Phrase: "according to Miller et al.(71"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0402830:Miller [Professional or Occupational Group]
   812   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "Piez et al.(72"

Phrase: ") ."

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a mechanism of APP binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "to collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "regulated by glycosaminoglycans"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0017973:Glycosaminoglycans [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C3536869:Glycosaminoglycan [Pharmacologic Substance]

Phrase: "that"

Phrase: "compete with APP"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   835 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "for an overlapping binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "of the 1 CB6 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "of collagen."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]
Processing 00000000.tx.146: Although both components can interact with glycosaminoglycans(21, 47) , our assay system allowed us to determine that inhibition of APP binding to collagen by heparin occurred on the collagen side by binding of heparin to collagen. 

Phrase: "Although"

Phrase: "both components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "can"

Phrase: "interact with glycosaminoglycans"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0017973:Glycosaminoglycans [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   756 E C3536869:Glycosaminoglycan [Pharmacologic Substance]

Phrase: "(21,"

Phrase: "47"

Phrase: ")"

Phrase: ","

Phrase: "our assay system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "that inhibition of APP binding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   831   C2245433:inhibition of protein binding [Organism Function]
   804   C2259198:inhibition of binding [Molecular Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "to collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "by heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "occurred on the collagen side"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0441987:Side [Spatial Concept]
   760   C1167364:collagen [Cell Component]
   760   C1709305:Occurred [Activity]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "by binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "to collagen."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]
Processing 00000000.tx.147: DISCUSSION Our results show that APP can interact with collagen types I and IV, and this interaction can be influenced by glycosaminoglycans. 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "can"

Phrase: "interact with collagen types I"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   851   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   851   C1167375:collagen type I [Cell Component]
   790   C0441729:Type I [Classification]
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332307:Types [Qualitative Concept]
   760   C1167364:collagen [Cell Component]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "IV,"

Phrase: "and"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "influenced by glycosaminoglycans."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0017973:Glycosaminoglycans [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   756 E C3536869:Glycosaminoglycan [Pharmacologic Substance]
Processing 00000000.tx.148: The binding of APP to collagen shows substrate specificity, is saturable, and Scatchard plot analysis suggests one binding site for collagen type I. 

Phrase: "The binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "substrate specificity,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0038592:Substrate Specificity [Quantitative Concept]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   861   C1710236:Substrate [Manufactured Object]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "is"

Phrase: "saturable,"

Phrase: "and"

Phrase: "Scatchard plot analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "one binding site for collagen type I."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0005456:Binding Site [Receptor]
   778   C0682969:Binding Site [Amino Acid Sequence]
   774   C1149167:collagen binding [Molecular Function]
   748   C0205145:Site [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
Processing 00000000.tx.149: Substantially reduced binding to denatured collagen is not observed, a finding that is in common with fibronectin binding to collagens (48) . In this study we concentrated on collagen type I that showed the highest affinity of those that were tested. 

Phrase: "Substantially"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "binding to denatured collagen"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C1149167:collagen binding [Molecular Function]
   770   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167364:collagen [Cell Component]
   770   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "is in common with fibronectin binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1621276:fibronectin binding [Molecular Function]
   753   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205214:Common [Quantitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "to collagens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009325:Collagens [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   966 E C1167364:collagen [Cell Component]
   916 E C0439689:Collagenous [Qualitative Concept]

Phrase: "(48"

Phrase: ") ."

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "concentrated on collagen type I"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   862   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1167375:collagen type I [Cell Component]
   806   C0441729:Type I [Classification]
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332307:Type [Qualitative Concept]
   760   C1167364:collagen [Cell Component]
   760   C1547052:*Type [Quantitative Concept]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the highest affinity of those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "that"

Phrase: "were"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.150: The affinity is in good agreement with the K values for the binding of J1 glycoproteins and NCAM to collagens(40, 49) . Collagen binding of APP was mapped to the carbohydrate domain of APP corresponding to amino acid residues 448-465, not including the carbohydrate attachment site at asparagine in position 467 (Table1). 

Phrase: "The affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "is in good agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205170:Good [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]

Phrase: "with the K values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "for the binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of J1 glycoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017968:Glycoproteins [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "and"

Phrase: "NCAM to collagens"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0282587:N-CAM [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C1334863:NCAM [Gene or Genome]
   790   C1705802:NCAM [Gene or Genome]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "49"

Phrase: ") . Collagen binding of APP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1149167:collagen binding [Molecular Function]
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167364:collagen [Cell Component]
   753   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "mapped to the carbohydrate domain of APP"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   790   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   781 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0162808:Protein Domain [Spatial Concept]
   762   C1514562:Protein Domain [Amino Acid Sequence]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007004:Carbohydrate [Carbohydrate]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]
   708   C0024779:Map [Manufactured Object]
   708   C1706473:Map [Conceptual Entity]

Phrase: "corresponding to amino acid residues 448-465,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the carbohydrate attachment site at asparagine"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0205675:Attachment site [Spatial Concept]
   753   C0185023:Attachment [Therapeutic or Preventive Procedure]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1947904:Attachment [Activity]
   753   C1999228:Attachment [Intellectual Product]
   753   C2825164:Site [Spatial Concept]

Phrase: "in position 467"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "(Table1"

Phrase: ")."
Processing 00000000.tx.151: The sequence of peptide CBP1 is conserved in rat, mouse, and human APP. 

Phrase: "The sequence of peptide CBP1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0920679:peptide sequence [Amino Acid Sequence]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "is"

Phrase: "conserved in rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:Rat, NOS [Mammal]
   790   C0034721:Rat [Mammal]

Phrase: "mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]
   708   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.152: A search in the ``Swiss-Prot'' Protein Data Bank did not reveal any significant homology to the CBP1 sequence in the known collagen-binding proteins such as fibronectin(50) , heat shock protein HSP47(51) , or bovine propolypeptide of von Willebrand factor (52) at the level of primary structure. 

Phrase: "A search in the ``Swiss-Prot'' Protein Data Bank"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1552603:search [Intellectual Product]
   742   C1706202:Search [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "any significant homology to the CBP1 sequence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   774   C0162775:Sequence Homology [Quantitative Concept]
   748   C1334043:Homology [Gene or Genome]
   748   C2697616:Homology [Qualitative Concept]
   724 E C0162774:Sequence Homolog [Molecular Sequence]

Phrase: "in the known collagen-binding proteins"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1149167:collagen binding [Molecular Function]
   812   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167364:collagen [Cell Component]
   812   C1167622:Binding [Molecular Function]
   741 E C0439689:Collagenous [Qualitative Concept]

Phrase: "such as fibronectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "heat shock protein HSP47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1413153:HSP47 [Gene or Genome]
   756   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(51"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "bovine propolypeptide of von Willebrand factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   864   C0084985:von Willebrand factor propolypeptide [Biologically Active Substance,Organic Chemical]

Phrase: "(52"

Phrase: ")"

Phrase: "at the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of primary structure."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.153: The inhibitory effect exerted through peptides CBP and CBP1 on APP collagen binding must be taken as an indication. 

Phrase: "The inhibitory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "exerted through peptides CBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015264:Exerted [Organism Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C3539643:CBP [Gene or Genome]

Phrase: "and"

Phrase: "CBP1 on APP collagen binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1833097:CBP1 [Gene or Genome]

Phrase: "must"

Phrase: "be"

Phrase: "taken as an indication."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0392360:indication [Idea or Concept]
   770   C1883727:Taken [Conceptual Entity]
   770   C3146298:Indication [Functional Concept]
   737 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.154: Direct binding of these synthetic peptides to collagen did occur, but could not be measured in terms of K values, because the tendency for self-aggregation of CBP and CBP1 observed by surface plasmon resonance as an undirected binding interfered with those measurements. 

Phrase: "Direct binding of these synthetic peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1149098:peptide binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "did"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "but"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "measured in terms of K values,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0042295:Values [Qualitative Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1708601:K' [Quantitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719   C1515273:Term [Temporal Concept]
   719 E C1522609:Value [Quantitative Concept]
   719   C1705313:Term [Idea or Concept]
   719   C2826302:TERM [Intellectual Product]

Phrase: "because"

Phrase: "the tendency for self-aggregation of CBP"

Phrase: "and"

Phrase: "CBP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1833097:CBP1 [Gene or Genome]

Phrase: "observed by surface plasmon resonance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0597731:Surface Plasmon Resonance [Molecular Biology Research Technique]
   760   C0205148:Surface [Spatial Concept]
   760   C0231881:Resonance [Finding]
   760   C0459800:resonance [Natural Phenomenon or Process]
   760   C0684213:Resonance [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "as an undirected binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "interfered with those measurements."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242485:measurements [Functional Concept]
   770   C0521102:Interfered [Qualitative Concept]
Processing 00000000.tx.155: The sequence of CBP is predicted to adopt a -strand conformation followed by the beginning of a -turn structure at residue 466, whereas CBP derived from APLP1 and APLP2 may adopt an -helical structure. 

Phrase: "The sequence of CBP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a -strand conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]

Phrase: "followed by the beginning of a -turn structure"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0439659:Beginning [Temporal Concept]
   744   C0541749:turn [Finding]
   744   C0678594:Structure [Spatial Concept]
   744   C1709743:Turn [Spatial Concept]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "at residue 466,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "whereas"

Phrase: "CBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539643:CBP [Gene or Genome]

Phrase: "derived from APLP1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1412466:APLP1 [Gene or Genome]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "APLP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: "may"

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "an -helical structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.156: This might explain why sequences corresponding to the collagen binding site of other members of the APP gene family were still able to inhibit binding, but the capacity to compete was drastically reduced in comparison with APP-CBP binding by more than a factor of 10. 

Phrase: "This"

Phrase: "might"

Phrase: "explain"

Phrase: "why sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "corresponding to the collagen binding site of other members"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   764   C0005456:Binding Site [Receptor]
   764   C0682969:Binding Site [Amino Acid Sequence]
   764   C1149167:collagen binding [Molecular Function]
   764   C2945843:Site of [Qualitative Concept]
   742   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   742   C0205145:Site [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C0680022:members [Population Group]
   742   C1145667:Binding [Activity]
   742   C1167364:collagen [Cell Component]
   742   C1167622:Binding [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]
   708 E C2698041:Member [Professional or Occupational Group]

Phrase: "of the APP gene family"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   875   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1517488:Gene Family [Gene or Genome]
   804   C0015576:Family [Family Group]
   804   C1704727:Family [Conceptual Entity]
   733 E C0241888:Familial [Functional Concept]
   717   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "still able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "but"

Phrase: "the capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "compete"

Phrase: "was"

Phrase: "drastically"

Phrase: "reduced in comparison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392756:Reduced [Qualitative Concept]
   790   C1707455:Comparison [Activity]

Phrase: "with APP-CBP binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0033618:Protein Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   717   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]

Phrase: "by more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than a factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "of 10."
Processing 00000000.tx.157: Additionally, peptides containing a -strand followed by a -turn are reported to be capable of undergoing isologous interaction in an antiparallel manner(53) . For instance the homophilic binding site of the cell adhesion molecule gp80 of Dictyostelium discoideum has been mapped to an octapeptide sequence YKLNVNDS in the NH-terminal globular domain (53, 54) and is known to mediate cell-cell adhesion via homophilic interaction. 

Phrase: "Additionally,"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a -strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "followed by a -turn"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0541749:turn [Finding]
   770   C1709743:Turn [Spatial Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "are"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "capable of undergoing isologous interaction"

Phrase: "in an antiparallel manner"

Phrase: "(53"

Phrase: ") ."

Phrase: "For instance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "the homophilic binding site of the cell adhesion molecule gp80 of Dictyostelium discoideum"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   780   C1149545:cell adhesion molecule binding [Molecular Function]
   750   C0005456:Binding Site [Receptor]
   750   C0682969:Binding Site [Amino Acid Sequence]
   750   C2945843:Site of [Qualitative Concept]
   735   C0205145:Site [Spatial Concept]
   735   C0243122:binding [Functional Concept]
   735   C1145667:Binding [Activity]
   735   C1167622:Binding [Molecular Function]
   735   C1515974:Site [Body Location or Region]
   735   C2825164:Site [Spatial Concept]
   713   C0596968:molecular site [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "mapped to an octapeptide sequence YKLNVNDS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]
   719   C0024779:Map [Manufactured Object]
   719   C1706473:Map [Conceptual Entity]

Phrase: "in the NH-terminal globular domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "(53,"

Phrase: "54"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell-cell adhesion via homophilic interaction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1154382:cell-cell adhesion [Cell Function]
   814   C1154395:homophilic cell adhesion [Cell Function]
   783   C0007577:Cell Adhesion [Cell Function]
   753   C0001511:Adhesion [Pathologic Function]
   753   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.158: It is remarkable that the -turn structure in gp80 is also induced by a potential glycosylation attachment sequence NXS(55) , as is the case for the CBP sequence of APP. 

Phrase: "It"

Phrase: "is"

Phrase: "remarkable"

Phrase: "that"

Phrase: "the -turn structure in gp80"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "also"

Phrase: "induced by a potential glycosylation attachment sequence NXS"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0017982:glycosylation [Natural Phenomenon or Process]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0185023:Attachment [Therapeutic or Preventive Procedure]
   744   C0205263:Induced [Functional Concept]
   744   C0376322:Glycosylation [Molecular Function]
   744   C1519249:Sequence [Functional Concept]
   744   C1947904:Attachment [Activity]
   744   C1999228:Attachment [Intellectual Product]
   744   C3245505:Potential [Qualitative Concept]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "as is"

Phrase: "the case for the CBP sequence of APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0868928:Case [Functional Concept]
   739   C1706255:CASE [Medical Device]
   739   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.159: Although APP contains at this position the only N-linked carbohydrate chain(56, 57) , according to our experiments it seems unlikely that the carbohydrate moiety is a regulator of collagen/gelatin binding activity, because deglycosylated rat brain APP retained the ability to bind to collagen as well as fusion proteins of APP expressed in bacteria. 

Phrase: "Although"

Phrase: "APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "contains at this position"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332256:contain [Functional Concept]
   770   C0733755:Position [Spatial Concept]
   770   C2700400:Contain [Activity]

Phrase: "the only N-linked carbohydrate chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0007004:Carbohydrate [Carbohydrate]
   804   C0337112:Chain [Manufactured Object]
   804   C1524075:Chain [Idea or Concept]

Phrase: "(56,"

Phrase: "57"

Phrase: ")"

Phrase: ","

Phrase: "according to our experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "it"

Phrase: "seems"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the carbohydrate moiety"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007004:Carbohydrate [Carbohydrate]

Phrase: "is"

Phrase: "a regulator of collagen/gelatin binding activity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0182953:REGULATOR [Medical Device]
   748   C1704734:Regulator [Medical Device]
   748   C1704735:Regulator [Conceptual Entity]

Phrase: "because"

Phrase: "deglycosylated rat brain APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind to collagen"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   790   C1145667:Bind [Activity]
   790   C1167364:collagen [Cell Component]
   790   C1167622:bind [Molecular Function]
   718 E C0439689:Collagenous [Qualitative Concept]

Phrase: "as well as"

Phrase: "fusion proteins of APP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   803   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   803   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   783   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332466:Fusion [Functional Concept]
   753   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "expressed in bacteria."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0004611:Bacteria [Bacterium]
   790   C1510439:bacteria [Functional Concept]
   790   C2347473:% Bacteria [Quantitative Concept]
   718 E C0521009:Bacterial [Qualitative Concept]
Processing 00000000.tx.160: But it still remains possible that the carbohydrate moiety induces a certain conformation of APP. 

Phrase: "But"

Phrase: "it still"

Phrase: "remains"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the carbohydrate moiety"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007004:Carbohydrate [Carbohydrate]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a certain conformation of APP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0033625:Protein Conformation [Spatial Concept]
   748   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.161: The observed self-aggregation of CBP led us to postulate the binding of radiolabeled rat brain APP to CBP that we analyzed in a solid-phase binding assay. 

Phrase: "The observed self-aggregation of CBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "postulate"

Phrase: "the binding of radiolabeled rat brain APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0033618:Protein Binding [Molecular Function]
   762   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "to CBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539643:CBP [Gene or Genome]

Phrase: "that"

Phrase: "we"

Phrase: "analyzed in a solid-phase binding assay."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0205208:Solid [Qualitative Concept]
   748   C0205390:Phase [Temporal Concept]
   748   C0243073:assay [Qualitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C0302909:Solid [Substance]
   748   C0936012:Analyzed [Research Activity]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1378566:Solid [Biomedical or Dental Material]
   748   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.162: We found binding to be saturable and recombinant APP, Zn(II), and heparin to be able to inhibit. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "saturable"

Phrase: "and"

Phrase: "recombinant APP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]
   708   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]

Phrase: "Zn"

Phrase: "(II"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "heparin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "inhibit."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]
Processing 00000000.tx.163: This provides evidence for APP-APP binding involving the AAQIRSQVMTHLRVIYER sequence. 

Phrase: "This"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence for APP-APP binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332120:Evidence [Functional Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the AAQIRSQVMTHLRVIYER sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.164: We were previously able to show that an allosteric effect on APP binding to heparin is caused by Zn(II)(21) , but not by other divalent ions. 

Phrase: "We"

Phrase: "were"

Phrase: "previously able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "an allosteric effect on APP binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "to heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "caused by Zn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "(II"

Phrase: ")"

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not by other divalent ions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0022023:Ions [Element, Ion, or Isotope]
   760   C1518422:Not [Functional Concept]
   726 E C1700702:ION [Functional Concept]
Processing 00000000.tx.165: Moreover, we observed that the electrophoretic mobility of CBP aggregates in capillary electrophoresis is dependent on the salt concentration. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "the electrophoretic mobility of CBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "in capillary electrophoresis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0201699:Electrophoresis, Capillary [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "is"

Phrase: "dependent on the salt concentration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.166: Therefore we conclude that binding of APP to CBP is driven by ionic forces, and separately from this, we propose a regulation by the divalent ions Zn(II) and Cu(II). 

Phrase: "Therefore"

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to CBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539643:CBP [Gene or Genome]

Phrase: "is"

Phrase: "driven by ionic forces,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0441722:forces [Phenomenon or Process]
   737   C0013126:Drive [Mental Process]
   737 E C0563538:Force [Phenomenon or Process]

Phrase: "and"

Phrase: "separately from this,"

Phrase: "we"

Phrase: "propose"

Phrase: "a regulation by the divalent ions Zn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "(II"

Phrase: ")"

Phrase: "and"

Phrase: "Cu(II"

Phrase: ")."
Processing 00000000.tx.167: We had shown earlier, in the case of Cu(II), that the modulation is likely due to the formation of APP aggregates and thus inhibiting the binding to the peptide on the solid support(28) . Our assay system allowed us to discern that inhibition of APP binding to collagen type I occurs on the APP or the collagen side, although both components can interact with glycosaminoglycans(47, 58) . We could demonstrate that APP interacts directly with the 1(I)CB6 fragment of collagen type I (Fig.6C and Fig.7B), independent from integrin-mediated adhesion. 

Phrase: "We"

Phrase: "had"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "earlier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of Cu(II"

Phrase: ")"

Phrase: ","

Phrase: "that"

Phrase: "the modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulation [Spatial Concept]

Phrase: "is"

Phrase: "likely due to the formation of APP aggregates"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   793   C1327111:amyloid precursor protein formation [Molecular Function]
   782   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   775 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0678226:Due to [Functional Concept]
           due
   760   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0597295:protein formation [Molecular Function]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205418:aggregates [Qualitative Concept]
   739   C0220781:formation [Biologic Function]
   739   C0332148:Likely [Qualitative Concept]
   739   C0439634:formation [Spatial Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0750492:Likely [Idea or Concept]
   739   C1522492:Formation [Functional Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "the binding to the peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1149098:peptide binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "on the solid support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0183683:Support [Medical Device]
   861   C1521721:Support [Conceptual Entity]

Phrase: "(28"

Phrase: ") ."

Phrase: "Our assay system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "discern"

Phrase: "that inhibition of APP binding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   831   C2245433:inhibition of protein binding [Organism Function]
   804   C2259198:inhibition of binding [Molecular Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "to collagen type I"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "occurs on the APP"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   814 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709305:Occur [Activity]
   753   C1709634:Precursor [Idea or Concept]
   753   C2745955:OCCUR [Temporal Concept]

Phrase: "or"

Phrase: "the collagen side,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "although"

Phrase: "both components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "can"

Phrase: "interact with glycosaminoglycans"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0017973:Glycosaminoglycans [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   756 E C3536869:Glycosaminoglycan [Pharmacologic Substance]

Phrase: "(47,"

Phrase: "58"

Phrase: ") ."

Phrase: "We"

Phrase: "could"

Phrase: "demonstrate"

Phrase: "that APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "interacts"

Phrase: "directly with the 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1947931:Directly [Qualitative Concept]

Phrase: "(I)CB6 fragment of collagen type I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "(Fig.6C"

Phrase: "and"

Phrase: "Fig.7B"

Phrase: ")"

Phrase: ","

Phrase: "independent from integrin-mediated adhesion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
Processing 00000000.tx.168: Integrins bind to 1(I)CB3 (integrin (21)) and 1(I)CB8 (integrin (11)) fragments of collagen(59, 60) . This interaction is regulated by heparin, and therefore both molecules probably share the same binding site on collagen. 

Phrase: "Integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "bind to 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "(I)CB3"

Phrase: "(integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "(21"

Phrase: ")"

Phrase: ")"

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(I)CB8"

Phrase: "(integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "(11"

Phrase: ")"

Phrase: ")"

Phrase: "fragments of collagen"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1167364:collagen [Cell Component]
   790   C1708096:Fragment [Qualitative Concept]
   718 E C0439689:Collagenous [Qualitative Concept]

Phrase: "(59,"

Phrase: "60"

Phrase: ") ."

Phrase: "This interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "regulated by heparin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "therefore"

Phrase: "both molecules probably"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "the same binding site on collagen."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0005456:Binding Site [Receptor]
   790   C0682969:Binding Site [Amino Acid Sequence]
   783   C1149167:collagen binding [Molecular Function]
   753   C0205145:Site [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.169: Heparin that is believed to act in vivo as a specific regulator of the structure and function of basement membranes(61) , or local variation in the concentration of heparin-like macromolecules, might be crucial for the interaction of APP and collagens in vivo. 

Phrase: "Heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "in vivo as a specific regulator of the structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "function of basement membranes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C0682568:membrane function [Body Part, Organ, or Organ Component]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "(61"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "local variation in the concentration of heparin-like macromolecules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:Variation [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "crucial for the interaction of APP"

Phrase: "and"

Phrase: "collagens"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009325:Collagens [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   966 E C1167364:collagen [Cell Component]
   916 E C0439689:Collagenous [Qualitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.170: A functional collagen binding site of APP is of great importance, since transmembrane APP could serve directly as a cell adhesion molecule, and the secreted forms might be involved in the regulation of cell interactions. 

Phrase: "A functional collagen binding site of APP"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0005456:Binding Site [Receptor]
   764   C0682969:Binding Site [Amino Acid Sequence]
   764   C1149167:collagen binding [Molecular Function]
   764   C2945843:Site of [Qualitative Concept]
   762   C0033618:Protein Binding [Molecular Function]
   762   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   742   C0205145:Site [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167364:collagen [Cell Component]
   742   C1167622:Binding [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "is of great importance,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0549177:Great [Quantitative Concept]
   770   C1704243:Great [Quantitative Concept]

Phrase: "since"

Phrase: "transmembrane APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]
   708   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]

Phrase: "could"

Phrase: "serve"

Phrase: "directly as a cell adhesion molecule,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   790   C0007577:Cell Adhesion [Cell Function]
   753   C0001511:Adhesion [Pathologic Function]
   753   C0007634:Cell [Cell]
   753   C0175633:Adhesion [Natural Phenomenon or Process]
   753   C0567416:Molecule [Substance]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1947931:Directly [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the secreted forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: "involved in the regulation of cell interactions."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0007582:Interactions, Cell [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1269647:Cell [Cell]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.171: In the periphery, APP might act as a transmembrane-signaling molecule. 

Phrase: "In the periphery,"

Phrase: "APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "might"

Phrase: "act as a transmembrane-signaling molecule."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1519315:Signaling Molecule [Biologically Active Substance]
   753   C0037083:Signaling [Cell Function]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0567416:Molecule [Substance]
   753   C1167322:transmembrane [Cell Component]
   753   C2752508:transmembrane [Cell Component]
   753   C3537152:signaling [Biologic Function]
   719 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.172: For instance platelets are activated by agonists such as thrombin and collagen (14, 15, 31) followed by the secretion of APP, which is an abundant platelet -granule protein. 

Phrase: "For instance platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005821:Platelets [Cell]
   861   C1963076:Platelets [Finding]

Phrase: "are"

Phrase: "activated by agonists"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243192:agonists [Pharmacologic Substance]
   790   C1879547:Activated [Activity]
   790   C2987634:agonists [Pharmacologic Substance]
   756 E C1515877:Activate [Functional Concept]

Phrase: "such as thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "(14,"

Phrase: "15,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "followed by the secretion of APP,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   800   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   789 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0332283:Followed by [Temporal Concept]
           followed
   770   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1159339:Protein Secretion [Cell Function]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "which"

Phrase: "is"

Phrase: "an abundant platelet -granule protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.173: It should be mentioned that platelets contain 20-50-fold higher concentrations of Zn(II) than plasma, and upon activation, platelets release Zn(II) to the external platelet surface(62) . At the microenvironment of the activated platelet in higher local concentrations, Zn(II) could shift the properties of APP into a different site of action, i.e. the regulation of the coagulation cascade by inhibiting factor XIa(63) . Collagen can also act as an effective substrate for neurite outgrowth from peripheral neurons and also promote outgrowth from at least some central neurons(64) . An involvement of APP in those processes was earlier suggested by Breen et al.(23) who found cell binding to a collagen substrate (neuron-neuron and neuron-glia binding) inhibited by antibodies against the extracellular portion of APP. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "mentioned"

Phrase: "that platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "20-50-fold higher concentrations of Zn"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "(II"

Phrase: ")"

Phrase: "than plasma,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and upon activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   790   C1879547:Activation [Activity]

Phrase: "platelets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005821:Platelets [Cell]
  1000   C1963076:Platelets [Finding]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "Zn"

Phrase: "(II"

Phrase: ")"

Phrase: "to the external platelet surface"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0005821:Platelet [Cell]
   827   C0205148:Surface [Spatial Concept]
   743 E C1963076:Platelets [Finding]

Phrase: "(62"

Phrase: ") ."

Phrase: "At the microenvironment"

Phrase: "of the activated platelet"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0005821:Platelet [Cell]
   777 E C1963076:Platelets [Finding]

Phrase: "in higher local concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "Zn"

Phrase: "(II"

Phrase: ")"

Phrase: "could"

Phrase: "shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "the properties of APP"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "into a different site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "of action,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the regulation of the coagulation cascade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C1326954:regulation of coagulation [Physiologic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by inhibiting factor XIa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0015524:Factor XIa [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(63"

Phrase: ") . Collagen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
  1000   C1167364:collagen [Cell Component]
   928 E C0439689:Collagenous [Qualitative Concept]

Phrase: "can"

Phrase: "also"

Phrase: "act as an effective substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]
   760   C1710236:Substrate [Manufactured Object]

Phrase: "for neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3158384:neurite outgrowth [Cell Function]
   861   C0085103:Neurite [Cell Component]

Phrase: "from peripheral neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0682700:Peripheral neuron [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "also"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "outgrowth from"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "some central neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0682701:Central neuron [Cell]
   861   C0027882:Neurons [Cell]
   861   C0205099:Central [Spatial Concept]
   861   C1879652:Central - [Laboratory Procedure]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(64"

Phrase: ") ."

Phrase: "An involvement of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in those processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "suggested by Breen et al.(23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0450348:23 [Quantitative Concept]
   719   C1705535:Suggest [Idea or Concept]

Phrase: ")"

Phrase: "who"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "cell binding to a collagen substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1149167:collagen binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "(neuron-neuron"

Phrase: "and"

Phrase: "neuron-glia binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "inhibited by antibodies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   795   C0301846:Inhibiting antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0311403:Inhibited [Qualitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "against the extracellular portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "of APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.174: Neuronal regeneration is associated with the expression of extracellular matrix proteins(65, 66) . A direct interaction of mature transmembrane APP with components of the extracellular matrix might reflect the importance of APP as a neuronal cell adhesion molecule. 

Phrase: "Neuronal regeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "is"

Phrase: "associated with the expression of extracellular matrix proteins"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   869   C3545197:expression of extracellular matrix proteins [Genetic Function]
   800   C0079323:Extracellular Matrix Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0015350:Extracellular Matrix [Tissue]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   750   C1171362:expression protein [Genetic Function]
   750   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0521119:Extracellular [Cell Component]
   744   C1704640:Matrix [Spatial Concept]
   744   C1706515:Matrix [Body Substance]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ") ."

Phrase: "A direct interaction of mature transmembrane APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0872079:interaction protein [Molecular Function]
   742   C1704675:Interaction [Functional Concept]

Phrase: "with components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "of the extracellular matrix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015350:Extracellular Matrix [Tissue]
   861   C0521119:Extracellular [Cell Component]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "might"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the importance of APP"

Phrase: "as a neuronal cell adhesion molecule."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1314772:Neuronal Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1334901:NEURONAL CELL ADHESION MOLECULE [Gene or Genome]
   923   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   923   C1154394:neuronal cell adhesion [Cell Function]
           neuron adhesion
   861   C0007577:Cell Adhesion [Cell Function]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0007634:Cell [Cell]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0567416:Molecule [Substance]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   741 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.175: The interaction of APP with extracellular matrix molecules may turn out to have a role in the pathogenesis of Alzheimer's disease. 

Phrase: "The interaction of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0872079:interaction protein [Molecular Function]
   753   C1704675:Interaction [Functional Concept]

Phrase: "with extracellular matrix molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "may"

Phrase: "turn out to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439787:Out [Spatial Concept]
   827   C0541749:turn [Finding]
   827   C0849355:Out [Qualitative Concept]
   827   C1709743:Turn [Spatial Concept]

Phrase: "have"

Phrase: "a role in the pathogenesis of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.176: Proteoglycans appear to be increased in the vicinity of A4 amyloid plaque deposition(67, 68) . Collagen-like molecules such as the A12 form of acetylcholinesterase are also increased in the areas of amyloid. 

Phrase: "Proteoglycans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033692:Proteoglycans [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "increased in the vicinity of A4 amyloid plaque deposition"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0333463:amyloid plaque [Acquired Abnormality]
           plaque
   764   C2936349:Plaque, Amyloid [Acquired Abnormality]
   762   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   762   C1705760:Amyloid Deposition [Finding]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011389:Plaque [Disease or Syndrome]
   742   C0205217:Increased [Quantitative Concept]
   742   C0332461:Plaque [Finding]
   742   C0333562:Deposition [Functional Concept]
   742   C0442805:Increased [Functional Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(67,"

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ") . Collagen-like molecules such as the A12 form of acetylcholinesterase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0567416:molecules [Substance]

Phrase: "are"

Phrase: "also"

Phrase: "increased in the areas of amyloid."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0205146:areas [Spatial Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C0017446:Area [Geographic Area]
Processing 00000000.tx.177: Alterations in the affinity of APP for extracellular matrix molecules by zinc may also be relevant to Alzheimer's disease(21, 27) . The normal processing of APP in the central nervous system may therefore be affected by APP-matrix interactions and deserves closer scrutiny. 

Phrase: "Alterations in the affinity of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1515926:Alteration [Idea or Concept]

Phrase: "for extracellular matrix molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "by zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "relevant to Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]

Phrase: "(21,"

Phrase: "27"

Phrase: ") ."

Phrase: "The normal processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0033666:protein processing [Molecular Function]
   748   C1709694:Processing [Activity]

Phrase: "in the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "therefore"

Phrase: "be"

Phrase: "affected by APP-matrix interactions"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   814   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   800 E C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0872079:interactions protein [Molecular Function]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392760:Affected [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1314939:Affected [Functional Concept]
   748   C1704640:Matrix [Spatial Concept]
   748   C1706515:Matrix [Body Substance]
   748   C1709634:Precursor [Idea or Concept]
   714 E C0001721:Affect [Mental Process]
   714   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "deserves"

Phrase: "closer scrutiny."
Processing 00000000.tx.178: FOOTNOTES * This work was supported by the Deutsche Forschungsgemeinschaft (through Grant SFB 317) and the Fonds der Chemischen Industrie of Germany. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Deutsche Forschungsgemeinschaft"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]

Phrase: "("

Phrase: "through Grant SFB 317"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018173:Grant [Quantitative Concept]
   827   C1548284:Grant [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the Fonds der Chemischen Industrie of Germany."
Processing 00000000.tx.179: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.180: This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore by hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "``advertisement''"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.181: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.182: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.183: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.184: 49-6221-56-68-49; 

Phrase: "49-6221-56-68-49"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0450387:68 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.185: Fax: 49-6221-56-58-91; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "49-6221-56-58-91"

Phrase: ";"
Processing 00000000.tx.186: bsa784{at}sun0.urz.uni-heidelberg.deberg.de . () The abbreviations used are: APP, amyloid protein precursor; 

Phrase: "bsa784{at}sun0.urz.uni-heidelberg.deberg.de ."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0011198:DE [Geographic Area]
   793   C0017480:DE [Geographic Area]
   793   C3541240:DE [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "APP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "amyloid protein precursor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.187: APPs, -secretase cleaved form of APP; 

Phrase: "APPs, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "form of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: ";"
Processing 00000000.tx.188: hs-APP, APP purified from human brain; 

Phrase: "hs-APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "purified from human brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0086418:Human [Human]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1998793:Purified [Functional Concept]

Phrase: ";"
Processing 00000000.tx.189: rn-APP, APP purified from rat brain; 

Phrase: "rn-APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   827   C1709634:Precursor [Idea or Concept]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "purified from rat brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1998793:Purified [Functional Concept]

Phrase: ";"
Processing 00000000.tx.190: A4, A4 amyloid protein; 

Phrase: "A4,"

Phrase: "A4 amyloid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.191: APLP, amyloid precursor like protein; 

Phrase: "APLP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412466:APLP [Gene or Genome]

Phrase: "amyloid precursor like protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN [Gene or Genome]
   881   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   881   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   819   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.192: BSA, bovine serum albumin; 

Phrase: "BSA,"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.193: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.194: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.195: CBP, collagen-binding peptide; 

Phrase: "CBP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539643:CBP [Gene or Genome]

Phrase: "collagen-binding peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   734   C1149167:collagen binding [Molecular Function]

Phrase: ";"
Processing 00000000.tx.196: NCAM, neural cell adhesion molecule. 

Phrase: "NCAM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282587:N-CAM [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1334863:NCAM [Gene or Genome]
  1000   C1705802:NCAM [Gene or Genome]

Phrase: "neural cell adhesion molecule."
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
  1000   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1413393:neural cell adhesion molecule [Gene or Genome]
   923   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   923   C1413564:neural adhesion molecule [Gene or Genome]
   861   C0007577:Cell Adhesion [Cell Function]
   861   C0027882:Neural cell [Cell]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0007634:Cell [Cell]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0567416:Molecule [Substance]
   812   C0599851:Neural [Functional Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   756 E C0027740:Nerve [Tissue]
   756 E C0027757:NERVE [Tissue]
   756 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   741 E C1521991:Molecular [Qualitative Concept]
   719 E C0027769:nervy [Sign or Symptom]
Processing 00000000.tx.197: ACKNOWLEDGEMENTS We are grateful to Andrea Schlicksupp and Santosh Pinto for technical assistance and thank Konrad Beyreuther for critically reading the manuscript. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Andrea Schlicksupp"

Phrase: "and"

Phrase: "Santosh Pinto for technical assistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0324179:Pinto [Mammal]
   760   C2700050:PINTO [Gene or Genome]

Phrase: "and"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Konrad Beyreuther for critically"

Phrase: "reading"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Reading [Daily or Recreational Activity]
  1000   C1705179:Reading [Finding]

Phrase: "the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.198: REFERENCES Wasco, W., Bupp, K., Magendantz, M., Gusella, J. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Bupp,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Magendantz,"

Phrase: "M."

Phrase: ","

Phrase: "Gusella,"

Phrase: "J."
Processing 00000000.tx.199: F., Tanzi, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.200: E., and Solomon, F. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Solomon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551833:Solomon [Population Group]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.201: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.202: Natl. 

Phrase: "Natl."
Processing 00000000.tx.203: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.204: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.205: U. 

Phrase: "U."
Processing 00000000.tx.206: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.207: A. 

Phrase: "A."
Processing 00000000.tx.208: 89, 10758-10762 [Abstract] Wasco, W., Gurubhagavatula, S., Dparadis, M., Romano, D. 

Phrase: "89,"

Phrase: "10758-10762"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wasco,"

Phrase: "W.,"

Phrase: "Gurubhagavatula,"

Phrase: "S."

Phrase: ","

Phrase: "Dparadis,"

Phrase: "M."

Phrase: ","

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.209: M., Sisodia, S. 

Phrase: "M."

Phrase: ","

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.210: S., Hyman, B. 

Phrase: "S."

Phrase: ","

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.211: T., Neve, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Neve,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.212: L., and Tanzi, R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.213: E. 

Phrase: "E."
Processing 00000000.tx.214: (1993) Nature Genet 5, 95-100 [Medline] [OrderarticleviaInfotrieve] Sprecher, C. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature Genet 5,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0325074:Genet [Mammal]
   827   C0349590:Nature [Idea or Concept]
   827   C1262865:Nature [Functional Concept]
   755 E C0205296:Natural [Functional Concept]

Phrase: "95-100"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sprecher,"

Phrase: "C."
Processing 00000000.tx.215: A., Grant, F. 

Phrase: "A.,"

Phrase: "Grant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.216: J., Grimm, G., O'Hara, P. 

Phrase: "J.,"

Phrase: "Grimm,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "O'Hara,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439114:O NOS [Intellectual Product]
   861   C2758676:Hara [Fish]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.217: J., Norris, F., Norris, K., and Foster, D. 

Phrase: "J.,"

Phrase: "Norris,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Norris,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "D."
Processing 00000000.tx.218: C. 

Phrase: "C."
Processing 00000000.tx.219: (1993) Biochemistry 32, 4481-4486 [Medline] [OrderarticleviaInfotrieve] Mller-Hill, B., and Beyreuther, K. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochemistry 32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4481-4486"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mller-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.220: (1989) Annu. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.221: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.222: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.223: 58, 287-307 [CrossRef][Medline] [OrderarticleviaInfotrieve] Selkoe, D. 

Phrase: "58,"

Phrase: "287-307"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.224: J. 

Phrase: "J."
Processing 00000000.tx.225: (1994) Annu. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.226: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.227: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.228: 17, 489-517 [CrossRef][Medline] [OrderarticleviaInfotrieve] Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Rossor, M., Owen, M., and Hardy, J. 

Phrase: "17,"

Phrase: "489-517"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M.-C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Giuffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A.,"

Phrase: "Irving,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "James,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mant,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rooke,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Roques,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Rossor,"

Phrase: "M."

Phrase: ","

Phrase: "Owen,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.229: (1991) Nature 349, 704-706 [CrossRef][Medline] [OrderarticleviaInfotrieve] Hendriks, L., van Duijn, C. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Nature 349,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "704-706"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hendriks,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "van Duijn,"

Phrase: "C."
Processing 00000000.tx.230: M., Cras, P., Cruts, M., Van Hul, W., van Harskamp, F., Warren, A., McInnis, M. 

Phrase: "M."

Phrase: ","

Phrase: "Cras,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Van Hul,"

Phrase: "W.,"

Phrase: "van Harskamp,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Warren,"

Phrase: "A.,"

Phrase: "McInnis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.231: G., Antonarakis, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Antonarakis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.232: E., Martin, J. 

Phrase: "E.,"

Phrase: "Martin,"

Phrase: "J."
Processing 00000000.tx.233: J., Hofman, A., and VanBroeckhoven, C. 

Phrase: "J.,"

Phrase: "Hofman,"

Phrase: "A.,"

Phrase: "and"

Phrase: "VanBroeckhoven,"

Phrase: "C."
Processing 00000000.tx.234: (1992) Nature Genet. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]
Processing 00000000.tx.235: 1, 218-221 [Medline] [OrderarticleviaInfotrieve] Levy, E., Carman, M. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "218-221"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Levy,"

Phrase: "E.,"

Phrase: "Carman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.236: D., Fernandez, M. 

Phrase: "D."

Phrase: ","

Phrase: "Fernandez,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.237: I., Power, M. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Power,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.238: D., Lieberburg, I., van, D. 

Phrase: "D."

Phrase: ","

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "van,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0557775:Van [Manufactured Object]

Phrase: "D."
Processing 00000000.tx.239: S., Bots, G. 

Phrase: "S."

Phrase: ","

Phrase: "Bots,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179376:BOT [Manufactured Object]
   966   C1633989:BOT [Quantitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.240: T., Luyendijk, W., and Frangione, B. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Luyendijk,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.241: (1990) Science 248, 1124-1126 [Medline] [OrderarticleviaInfotrieve] Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1124-1126"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.242: M., Oshima, J., Pettingell, W. 

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "J.,"

Phrase: "Pettingell,"

Phrase: "W."
Processing 00000000.tx.243: H., Yu, C., Jondro, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.244: D., Schmidt, S. 

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.245: D., Wang, K., Crowley, A. 

Phrase: "D."

Phrase: ","

Phrase: "Wang,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Crowley,"

Phrase: "A."
Processing 00000000.tx.246: C., Fu, Y.-H., Guenette, S. 

Phrase: "C., Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C1424823:FU [Gene or Genome]

Phrase: "Y.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.247: Y., Galas, D., Nemens, E., Wijsman, E. 

Phrase: "Y.,"

Phrase: "Galas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0082651:gala [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1439334:GALA [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Wijsman,"

Phrase: "E."
Processing 00000000.tx.248: M., Bird, T. 

Phrase: "M."

Phrase: ","

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.249: D., Schellenberg, G. 

Phrase: "D."

Phrase: ","

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.250: D., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.251: E. 

Phrase: "E."
Processing 00000000.tx.252: (1995) Science 269, 973-977 [Medline] [OrderarticleviaInfotrieve] Corder, E. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "973-977"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Corder,"

Phrase: "E."
Processing 00000000.tx.253: H., Saunders, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.254: M., Strittmatter, W. 

Phrase: "M."

Phrase: ","

Phrase: "Strittmatter,"

Phrase: "W."
Processing 00000000.tx.255: J., Schmechel, D. 

Phrase: "J.,"

Phrase: "Schmechel,"

Phrase: "D."
Processing 00000000.tx.256: E., Gaskell, P. 

Phrase: "E.,"

Phrase: "Gaskell,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.257: C., Small, G. 

Phrase: "C., Small, G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.258: W., Roses, A. 

Phrase: "W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035853:Roses [Plant]
   827 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.259: D., Haines, J. 

Phrase: "D."

Phrase: ","

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.260: L., and Pericak-Vance, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.261: A. 

Phrase: "A."
Processing 00000000.tx.262: (1993) Science 261, 921-923 [Medline] [OrderarticleviaInfotrieve] Sherrington, R., Rogaev, E. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 261,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "921-923"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E."
Processing 00000000.tx.263: I., Liang, Y., Rogaeva, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.264: A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J. 

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Foncin,"

Phrase: "J."
Processing 00000000.tx.265: F., Bruni, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bruni,"

Phrase: "A."
Processing 00000000.tx.266: C., Montesi, M. 

Phrase: "C., Montesi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.267: P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Rainero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pinessi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pollen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032385:Pollen [Plant]
  1000   C0795585:POLLEN [Organic Chemical,Pharmacologic Substance]
  1000   C1320238:Pollen [Immunologic Factor]

Phrase: "D."

Phrase: ","

Phrase: "Brookes,"

Phrase: "A.,"

Phrase: "Sanseau,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Polinsky,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.268: J., Wasco, W., Dasilva, H. 

Phrase: "J.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Dasilva,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.269: A. 

Phrase: "A."
Processing 00000000.tx.270: R., Haines, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.271: L., Pericak-Vance, M. 

Phrase: "L., Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.272: A., Tanzi, R. 

Phrase: "A.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.273: E., Roses, A. 

Phrase: "E.,"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.274: D., Fraser, P. 

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.275: E., Rommens, J. 

Phrase: "E.,"

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.276: M., and St. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.277: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.278: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.279: (1995) Nature 375, 754-760 [CrossRef][Medline] [OrderarticleviaInfotrieve] Oltersdorf, T., Fritz, L. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 375,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "754-760"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fritz,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414819:FRITZ [Gene or Genome]
  1000   C2681211:fritz [Gene or Genome]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.280: C., Schenk, D. 

Phrase: "C., Schenk,"

Phrase: "D."
Processing 00000000.tx.281: B., Lieberburg, I., Johnson-Wood, K., Beattie, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Beattie,"

Phrase: "E."
Processing 00000000.tx.282: C., Ward, P. 

Phrase: "C., Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1305702:Ward [Health Care Related Organization,Manufactured Object]
   861   C1547134:Ward [Idea or Concept]
   861   C2355574:Ward [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.283: J., Blacher, R. 

Phrase: "J.,"

Phrase: "Blacher,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.284: W., Dovey, H. 

Phrase: "W., Dovey,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.285: F., and Sinha, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Sinha,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.286: (1989) Nature 341, 144-147 [CrossRef][Medline] [OrderarticleviaInfotrieve] Kounnas, M. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Nature 341,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "144-147"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kounnas,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.287: Z., Moir, R. 

Phrase: "Z.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.288: D., Rebeck, G. 

Phrase: "D."

Phrase: ","

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.289: W., Bush, A. 

Phrase: "W., Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.290: I., Argraves, W. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Argraves,"

Phrase: "W."
Processing 00000000.tx.291: S., Tanzi, R. 

Phrase: "S."

Phrase: ","

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.292: E., Hyman, B. 

Phrase: "E.,"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.293: T., and Strickland, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.294: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.295: (1995) Cell 82, 331-340 [Medline] [OrderarticleviaInfotrieve] Smith, R. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 82,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "331-340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.296: P., Higuchi, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Higuchi,"

Phrase: "D."
Processing 00000000.tx.297: A., and Broze, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Broze,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.298: J. 

Phrase: "J."
Processing 00000000.tx.299: (1990) Science 248, 1126-1128 [Medline] [OrderarticleviaInfotrieve] Van Nostrand, W. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1126-1128"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Van Nostrand,"

Phrase: "W."
Processing 00000000.tx.300: E., Schmaier, A. 

Phrase: "E.,"

Phrase: "Schmaier,"

Phrase: "A."
Processing 00000000.tx.301: H., Farrow, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Farrow,"

Phrase: "J."
Processing 00000000.tx.302: S., and Cunningham, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Cunningham,"

Phrase: "D."
Processing 00000000.tx.303: D. 

Phrase: "D."
Processing 00000000.tx.304: (1990) Science 248, 745-748 [Medline] [OrderarticleviaInfotrieve] Roch, J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "745-748"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Roch,"

Phrase: "J."
Processing 00000000.tx.305: M., Shapiro, I. 

Phrase: "M."

Phrase: ","

Phrase: "Shapiro,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.306: P., Sundsmo, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sundsmo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.307: P., Otero, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Otero,"

Phrase: "D."
Processing 00000000.tx.308: A., Refolo, L. 

Phrase: "A.,"

Phrase: "Refolo,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.309: M., Robakis, N. 

Phrase: "M."

Phrase: ","

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.310: K., and Saitoh, T. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.311: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.312: Biol. 

Phrase: "Biol."
Processing 00000000.tx.313: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.314: 267, 2214-2221 [Abstract/Free FullText] Milward, E. 

Phrase: "267,"

Phrase: "2214-2221"

Phrase: "[Abstract/Free FullText"

Phrase: "] Milward,"

Phrase: "E."
Processing 00000000.tx.315: A., Papadopoulos, R., Fuller, S. 

Phrase: "A.,"

Phrase: "Papadopoulos,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fuller,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.316: J., Moir, R. 

Phrase: "J.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.317: D., Small, D., Beyreuther, K., and Masters, C. 

Phrase: "D."

Phrase: ","

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.318: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.319: (1992) Neuron 9, 129-137 [Medline] [OrderarticleviaInfotrieve] Saitoh, T., Sundsmo, M., Roch, J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Neuron 9,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "129-137"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Saitoh,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sundsmo,"

Phrase: "M."

Phrase: ","

Phrase: "Roch,"

Phrase: "J."
Processing 00000000.tx.320: M., Kimura, N., Cole, G., Schubert, D., Oltersdorf, T., and Schenk, D. 

Phrase: "M."

Phrase: ","

Phrase: "Kimura,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cole,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schubert,"

Phrase: "D."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.321: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.322: (1989) Cell 58, 615-622 [Medline] [OrderarticleviaInfotrieve] Schubert, D., LaCorbiere, M., Saitoh, T., and Cole, G. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 58,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "615-622"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schubert,"

Phrase: "D."

Phrase: ","

Phrase: "LaCorbiere,"

Phrase: "M."

Phrase: ","

Phrase: "Saitoh,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Cole,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.323: (1989) Proc. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.324: Natl. 

Phrase: "Natl."
Processing 00000000.tx.325: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.326: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.327: U. 

Phrase: "U."
Processing 00000000.tx.328: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.329: A. 

Phrase: "A."
Processing 00000000.tx.330: 86, 2066-2069 [Abstract] Multhaup, G., Bush, A. 

Phrase: "86,"

Phrase: "2066-2069"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.331: I., Pollwein, P., Masters, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pollwein,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.332: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.333: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.334: Protein Chem. 

Phrase: "Protein Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.335: 11, 398-399 Multhaup, G. 

Phrase: "11,"

Phrase: "398-399 Multhaup,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.336: (1994) Biochimie (Paris) 76, 304-311 Klier, F. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochimie"

Phrase: "(Paris"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: ")"

Phrase: "76,"

Phrase: "304-311 Klier,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.337: G., Cole, G., Stallcup, W., and Schubert, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cole,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Stallcup,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Schubert,"

Phrase: "D."
Processing 00000000.tx.338: (1990) Brain Res. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.339: 515, 336-342 [Medline] [OrderarticleviaInfotrieve] Breen, K. 

Phrase: "515,"

Phrase: "336-342"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Breen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.340: C., Bruce, M., and Anderton, B. 

Phrase: "C., Bruce,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1332417:BRUCE [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.341: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.342: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.343: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.344: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.345: 28, 90-100 [Medline] [OrderarticleviaInfotrieve] Kibbey, M. 

Phrase: "28,"

Phrase: "90-100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kibbey,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.346: C., Jucker, M., Weeks, B. 

Phrase: "C., Jucker,"

Phrase: "M."

Phrase: ","

Phrase: "Weeks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439230:weeks [Temporal Concept]
   966 E C0332174:/week [Temporal Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.347: S., Neve, R. 

Phrase: "S."

Phrase: ","

Phrase: "Neve,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.348: L., Van, N. 

Phrase: "L., Van,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557775:Van [Manufactured Object]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.349: W., and Kleinman, H. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Kleinman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.350: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.351: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.352: Natl. 

Phrase: "Natl."
Processing 00000000.tx.353: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.354: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.355: U. 

Phrase: "U."
Processing 00000000.tx.356: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.357: A. 

Phrase: "A."
Processing 00000000.tx.358: 90, 10150-10153 [Abstract] Narindrasorasak, S., Lowery, D. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "10150-10153"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Narindrasorasak,"

Phrase: "S."

Phrase: ","

Phrase: "Lowery,"

Phrase: "D."
Processing 00000000.tx.359: E., Altman, R. 

Phrase: "E.,"

Phrase: "Altman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.360: A., Gonzalez-DeWhitt, P., Greenberg, B. 

Phrase: "A.,"

Phrase: "Gonzalez-DeWhitt,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Greenberg,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.361: D., and Kisilevsky, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Kisilevsky,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.362: (1992) Lab. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.363: Invest. 

Phrase: "Invest."
Processing 00000000.tx.364: 67, 643-652 [Medline] [OrderarticleviaInfotrieve] Small, D. 

Phrase: "67,"

Phrase: "643-652"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Small, D."
Processing 00000000.tx.365: H., Nurcombe, V., Reed, G., Clarris, H., Moir, R., Beyreuther, K., and Masters, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nurcombe,"

Phrase: "V.,"

Phrase: "Reed,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Clarris,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Moir,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.366: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.367: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.368: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.369: 14, 2117-2127 [Abstract] Bush, A. 

Phrase: "14,"

Phrase: "2117-2127"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.370: I., Multhaup, G., Moir, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.371: D., Williamson, T. 

Phrase: "D."

Phrase: ","

Phrase: "Williamson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.372: G., Small, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.373: H., Rumble, B., Pollwein, P., Beyreuther, K., and Masters, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rumble,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pollwein,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.374: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.375: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.376: Biol. 

Phrase: "Biol."
Processing 00000000.tx.377: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.378: 268, 16109-16112 [Abstract/Free FullText] Hesse, L., Beher, D., Masters, C. 

Phrase: "268,"

Phrase: "16109-16112"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hesse,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Beher,"

Phrase: "D."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.379: L., and Multhaup, G. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Multhaup,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.380: (1994) FEBS Lett. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.381: 349, 109-116 [CrossRef][Medline] [OrderarticleviaInfotrieve] Bush, A. 

Phrase: "349,"

Phrase: "109-116"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.382: I., Pettingell, W. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pettingell,"

Phrase: "W."
Processing 00000000.tx.383: H., Jr., DeParadis, M., Tanzi, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "DeParadis,"

Phrase: "M."

Phrase: ","

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.384: E., and Wasco, W. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Wasco,"

Phrase: "W."
Processing 00000000.tx.385: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.386: Biol. 

Phrase: "Biol."
Processing 00000000.tx.387: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.388: 269, 26618-26621 [Abstract/Free FullText] Multhaup, G., Bush, A. 

Phrase: "269,"

Phrase: "26618-26621"

Phrase: "[Abstract/Free FullText"

Phrase: "] Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.389: I., Pollwein, P., and Masters, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pollwein,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.390: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.391: (1994) FEBS Lett. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.392: 355, 151-154 [CrossRef][Medline] [OrderarticleviaInfotrieve] Bush, A. 

Phrase: "355,"

Phrase: "151-154"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.393: I., Martins, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.394: N., Rumble, B., Moir, R., Fuller, S., Milward, E., Currie, J., Ames, D., Weidemann, A., Fischer, P., Multhaup, G., Beyreuther, K., and Masters, C. 

Phrase: "N., Rumble,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Moir,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fuller,"

Phrase: "S."

Phrase: ","

Phrase: "Milward,"

Phrase: "E.,"

Phrase: "Currie,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440524:Curry [Immunologic Factor]

Phrase: "J.,"

Phrase: "Ames,"

Phrase: "D."

Phrase: ","

Phrase: "Weidemann,"

Phrase: "A.,"

Phrase: "Fischer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.395: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.396: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.397: Biol. 

Phrase: "Biol."
Processing 00000000.tx.398: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.399: 265, 15977-15983 [Abstract/Free FullText] Santoro, S. 

Phrase: "265,"

Phrase: "15977-15983"

Phrase: "[Abstract/Free FullText"

Phrase: "] Santoro,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.400: A. 

Phrase: "A."
Processing 00000000.tx.401: (1986) Cell 46, 913-920 [Medline] [OrderarticleviaInfotrieve] Barany, G., and Merrifield, B. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Cell 46,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "913-920"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Barany,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Merrifield,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.402: (1981) The Peptides (Gross, E., and Meienhofer, J., eds) Vol. 

Phrase: "(1981"

Phrase: ")"

Phrase: "The Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(Gross, E.,"

Phrase: "and"

Phrase: "Meienhofer,"

Phrase: "J.,"

Phrase: "eds) Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.403: 2, Academic Press, Inc., New York Kunkel, T. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Academic Press,"

Phrase: "Inc.,"

Phrase: "New York Kunkel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.404: A. 

Phrase: "A."
Processing 00000000.tx.405: (1985) Proc. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.406: Natl. 

Phrase: "Natl."
Processing 00000000.tx.407: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.408: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.409: U. 

Phrase: "U."
Processing 00000000.tx.410: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.411: A. 

Phrase: "A."
Processing 00000000.tx.412: 82, 488-492 [Abstract] Weidemann, A., Knig, G., Bunke, D., Fischer, P., Salbaum, J. 

Phrase: "82,"

Phrase: "488-492"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Weidemann,"

Phrase: "A.,"

Phrase: "Knig,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bunke,"

Phrase: "D."

Phrase: ","

Phrase: "Fischer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.413: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.414: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.415: (1989) Cell 57, 115-126 [Medline] [OrderarticleviaInfotrieve] Gross, E., and Witkop, B. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 57,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "115-126"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gross, E.,"

Phrase: "and"

Phrase: "Witkop,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.416: (1961) J. 

Phrase: "(1961"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.417: Am. 

Phrase: "Am."
Processing 00000000.tx.418: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.419: Soc. 

Phrase: "Soc."
Processing 00000000.tx.420: 83, 1510-1511 Kang, J., Lemaire, H. 

Phrase: "83,"

Phrase: "1510-1511 Kang,"

Phrase: "J.,"

Phrase: "Lemaire,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.421: G., Unterbeck, A., Salbaum, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.422: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.423: L., Grzeschik, K. 

Phrase: "L., Grzeschik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.424: H., Multhaup, G., Beyreuther, K., and Mller-Hill, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mller-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.425: (1987) Nature 325, 733-736 [CrossRef][Medline] [OrderarticleviaInfotrieve] Vuorio, E., and deCrombrugghe, B. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Nature 325,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "733-736"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vuorio,"

Phrase: "E.,"

Phrase: "and"

Phrase: "deCrombrugghe,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.426: (1990) Annu. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.427: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.428: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.429: 59, 837-872 [CrossRef][Medline] [OrderarticleviaInfotrieve] Scatchard, G. 

Phrase: "59,"

Phrase: "837-872"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Scatchard,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.430: (1949) Ann. 

Phrase: "(1949"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.431: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.432: Y. 

Phrase: "Y."
Processing 00000000.tx.433: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.434: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.435: 51, 660-672 Probstmeier, R., Khn, K., and Schachner, M. 

Phrase: "51,"

Phrase: "660-672 Probstmeier,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Khn,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Schachner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.436: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.437: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.438: 53, 1794-1801 [Medline] [OrderarticleviaInfotrieve] Chou, P. 

Phrase: "53,"

Phrase: "1794-1801"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chou,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.439: Y., and Fasman, G. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Fasman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.440: D. 

Phrase: "D."
Processing 00000000.tx.441: (1978) Adv. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.442: Enzymol. 

Phrase: "Enzymol."
Processing 00000000.tx.443: 47, 45-148 [Medline] [OrderarticleviaInfotrieve] Falchuk, K. 

Phrase: "47,"

Phrase: "45-148"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Falchuk,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.444: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.445: (1987) in Principles of Internal Medicine (Braunwald, E., Isselbacher, K. J., Petersdorf, R. G., Wilson, J. D., Martin, J. B., and Fauci, A. S., eds) pp. 

Phrase: "(1987"

Phrase: ")"

Phrase: "in Principles"

Phrase: "of Internal Medicine"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0021782:Internal Medicine [Biomedical Occupation or Discipline]
  1000   C1555750:Internal Medicine [Intellectual Product]
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]
   861   C0205102:Internal [Spatial Concept]
   861   C1553872:Internal [Intellectual Product]
   861   C1619620:Internal [Intellectual Product]

Phrase: "(Braunwald,"

Phrase: "E.,"

Phrase: "Isselbacher,"

Phrase: "K. J.,"

Phrase: "Petersdorf,"

Phrase: "R. G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Wilson,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Martin,"

Phrase: "J. B.,"

Phrase: "and"

Phrase: "Fauci,"

Phrase: "A."

Phrase: "S."

Phrase: ","

Phrase: "eds) pp."
Processing 00000000.tx.446: 418-421, McGraw-Hill, New York Jackson, M. 

Phrase: "418-421,"

Phrase: "McGraw-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "New York Jackson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.447: J. 

Phrase: "J."
Processing 00000000.tx.448: (1989) Zinc in Human Biology (Mills, C. F., ed) Springer- Verlag, London Multhaup, G., Masters, C. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Zinc in Human Biology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "(Mills,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599997:mills [Manufactured Object]

Phrase: "C. F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "ed) Springer- Verlag,"

Phrase: "London Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.449: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.450: (1993) Biol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biol."
Processing 00000000.tx.451: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.452: Hoppe-Seyler 374, 1-8 [Medline] [OrderarticleviaInfotrieve] Lindahl, U., Hk, M., Kjellen, L., Johansson, S., and Robinson, J. 

Phrase: "Hoppe-Seyler 374,"

Phrase: "1-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lindahl,"

Phrase: "U.,"

Phrase: "Hk,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019907:HK [Geographic Area]
  1000   C2681927:HK [Gene or Genome]
  1000   C2987742:HK [Fish]

Phrase: "M."

Phrase: ","

Phrase: "Kjellen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Johansson,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.453: (1984) Annu. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.454: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.455: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.456: 53, 847-869 [CrossRef][Medline] [OrderarticleviaInfotrieve] Keller, K. 

Phrase: "53,"

Phrase: "847-869"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Keller,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.457: M., Keller, J. 

Phrase: "M."

Phrase: ","

Phrase: "Keller,"

Phrase: "J."
Processing 00000000.tx.458: M., and Khn, K. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Khn,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.459: (1986) Biochim. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.460: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.461: Acta 882, 1-5 [Medline] [OrderarticleviaInfotrieve] Lindahl, U., and Hk, M. 

Phrase: "Acta 882,"

Phrase: "1-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lindahl,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Hk,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019907:HK [Geographic Area]
  1000   C2681927:HK [Gene or Genome]
  1000   C2987742:HK [Fish]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.462: (1978) Annu. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.463: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.464: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.465: 47, 385-417 [CrossRef][Medline] [OrderarticleviaInfotrieve] Ruoshlahti, E., Hayman, E. 

Phrase: "47,"

Phrase: "385-417"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ruoshlahti,"

Phrase: "E.,"

Phrase: "Hayman,"

Phrase: "E."
Processing 00000000.tx.466: G., Pierschbacher, M., and Engvall, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pierschbacher,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Engvall,"

Phrase: "E."
Processing 00000000.tx.467: (1982) Methods Enzymol. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.468: 82, 803-831 [Medline] [OrderarticleviaInfotrieve] Faissner, A., Kruse, J., Khn, K., and Schachner, M. 

Phrase: "82,"

Phrase: "803-831"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Faissner,"

Phrase: "A.,"

Phrase: "Kruse,"

Phrase: "J.,"

Phrase: "Khn,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Schachner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.469: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.470: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.471: 54, 1004-1015 [Medline] [OrderarticleviaInfotrieve] Ingham, K. 

Phrase: "54,"

Phrase: "1004-1015"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ingham,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.472: C., Brew, S. 

Phrase: "C., Brew,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700104:brew [Occupational Activity]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.473: A., and Migliorini, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Migliorini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.474: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.475: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.476: Biol. 

Phrase: "Biol."
Processing 00000000.tx.477: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.478: 264, 16977-16980 [Abstract/Free FullText] Hirayoshi, K., Kudo, H., Takechi, H., Nakai, A., Iwamatsu, A., Yamada, K. 

Phrase: "264,"

Phrase: "16977-16980"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hirayoshi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kudo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takechi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakai,"

Phrase: "A.,"

Phrase: "Iwamatsu,"

Phrase: "A.,"

Phrase: "Yamada,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.479: M., and Nagata, K. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Nagata,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.480: (1991) Mol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.481: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.482: Biol. 

Phrase: "Biol."
Processing 00000000.tx.483: 11, 4036-4044 [Medline] [OrderarticleviaInfotrieve] Takagi, J., Asai, H., and Saito, Y. 

Phrase: "11,"

Phrase: "4036-4044"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Takagi,"

Phrase: "J.,"

Phrase: "Asai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Saito,"

Phrase: "Y."
Processing 00000000.tx.484: (1992) Biochemistry 31, 8530-8534 [Medline] [OrderarticleviaInfotrieve] Kamboj, R. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochemistry 31,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005477:Biochemistry [Occupation or Discipline]
   861   C0450355:31 [Intellectual Product]

Phrase: "8530-8534"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kamboj,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.485: K., Gariepy, J., and Siu, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gariepy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Siu,"

Phrase: "C."
Processing 00000000.tx.486: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.487: (1989) Cell 59, 615-625 [Medline] [OrderarticleviaInfotrieve] Kamboj, R. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 59,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "615-625"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kamboj,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.488: K., Wong, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wong,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.489: M., Lam, T. 

Phrase: "M."

Phrase: ","

Phrase: "Lam,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.490: Y., and Siu, C. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Siu,"

Phrase: "C."
Processing 00000000.tx.491: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.492: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.493: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.494: 107, 1835-1843 [Abstract] Marshall, R. 

Phrase: "107,"

Phrase: "1835-1843"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.495: D. 

Phrase: "D."
Processing 00000000.tx.496: (1974) Biochem. 

Phrase: "(1974"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.497: Soc. 

Phrase: "Soc."
Processing 00000000.tx.498: Symp. 

Phrase: "Symp."
Processing 00000000.tx.499: 40, 17-26 [Medline] [OrderarticleviaInfotrieve] Dyrks, T., Weidemann, A., Multhaup, G., Salbaum, J. 

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "17-26"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dyrks,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Weidemann,"

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.500: M., Lemaire, H. 

Phrase: "M."

Phrase: ","

Phrase: "Lemaire,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.501: G., Kang, J., Mller-Hill, B., Masters, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kang,"

Phrase: "J.,"

Phrase: "Mller-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.502: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.503: (1988) EMBO J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.504: 7, 949-957 [Abstract] Pahlsson, P., Shakin, E. 

Phrase: "7,"

Phrase: "949-957"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Pahlsson,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Shakin,"

Phrase: "E."
Processing 00000000.tx.505: S., and Spitalnik, S. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Spitalnik,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.506: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.507: (1992) Biochem. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.508: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.509: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.510: Commun. 

Phrase: "Commun."
Processing 00000000.tx.511: 189, 1667-1673 [Medline] [OrderarticleviaInfotrieve] Cole, G. 

Phrase: "189,"

Phrase: "1667-1673"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cole,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.512: J., and Glaser, L. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Glaser,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.513: (1986) J. 

Phrase: "(1986"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.514: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.515: 100, 403-412 Gullberg, D., Gehlsen, K. 

Phrase: "100,"

Phrase: "403-412 Gullberg,"

Phrase: "D."

Phrase: ","

Phrase: "Gehlsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.516: R., Turner, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Turner,"

Phrase: "D."
Processing 00000000.tx.517: C., Ahlen, K., Zijenah, L. 

Phrase: "C., Ahlen,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zijenah,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.518: S., Barnes, M. 

Phrase: "S."

Phrase: ","

Phrase: "Barnes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.519: J., and Rubin, K. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.520: (1992) EMBO J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.521: 11, 3865-3873 [Abstract] Staatz, W. 

Phrase: "11,"

Phrase: "3865-3873"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Staatz,"

Phrase: "W."
Processing 00000000.tx.522: D., Walsh, J. 

Phrase: "D."

Phrase: ","

Phrase: "Walsh,"

Phrase: "J."
Processing 00000000.tx.523: J., Pexton, T., and Santoro, S. 

Phrase: "J.,"

Phrase: "Pexton,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Santoro,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.524: A. 

Phrase: "A."
Processing 00000000.tx.525: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.526: Biol. 

Phrase: "Biol."
Processing 00000000.tx.527: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.528: 265, 4778-4781 [Abstract/Free FullText] Yurchenco, P. 

Phrase: "265,"

Phrase: "4778-4781"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yurchenco,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.529: D., Cheng, Y. 

Phrase: "D."

Phrase: ","

Phrase: "Cheng,"

Phrase: "Y."
Processing 00000000.tx.530: S., and Schittny, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Schittny,"

Phrase: "J."
Processing 00000000.tx.531: C. 

Phrase: "C."
Processing 00000000.tx.532: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.533: Biol. 

Phrase: "Biol."
Processing 00000000.tx.534: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.535: 265, 3981-3991 [Abstract/Free FullText] Aktulga, A., and Ulatin, O. 

Phrase: "265,"

Phrase: "3981-3991"

Phrase: "[Abstract/Free FullText"

Phrase: "] Aktulga,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Ulatin,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.536: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.537: (1975) in Excerpta Medica (Aktulga, A., ed) pp. 

Phrase: "(1975"

Phrase: ")"

Phrase: "in Excerpta Medica"

Phrase: "(Aktulga,"

Phrase: "A.,"

Phrase: "ed) pp."
Processing 00000000.tx.538: 185-191, Amsterdam Wagner, S. 

Phrase: "185-191,"

Phrase: "Amsterdam Wagner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.539: L., Siegel, R. 

Phrase: "L., Siegel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.540: S., Vedvick, T. 

Phrase: "S."

Phrase: ","

Phrase: "Vedvick,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.541: S., Raschke, W. 

Phrase: "S."

Phrase: ","

Phrase: "Raschke,"

Phrase: "W."
Processing 00000000.tx.542: C., and Van, N. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Van,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0557775:Van [Manufactured Object]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.543: W. 

Phrase: "W."
Processing 00000000.tx.544: (1992) Biochem. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.545: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.546: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.547: Commun. 

Phrase: "Commun."
Processing 00000000.tx.548: 186, 1138-1145 [Medline] [OrderarticleviaInfotrieve] Sanes, J. 

Phrase: "186,"

Phrase: "1138-1145"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sanes,"

Phrase: "J."
Processing 00000000.tx.549: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.550: (1989) Annu. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.551: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.552: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.553: 12, 491-516 [CrossRef][Medline] [OrderarticleviaInfotrieve] Liesi, P., Kaakkola, S., Dahl, D., and Vaheri, A. 

Phrase: "12,"

Phrase: "491-516"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Liesi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kaakkola,"

Phrase: "S."

Phrase: ","

Phrase: "Dahl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206461:DAL [Carbohydrate,Pharmacologic Substance]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Vaheri,"

Phrase: "A."
Processing 00000000.tx.554: (1984) EMBO J. 

Phrase: "(1984"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.555: 3, 683-686 [Abstract] Lefcort, F., Venstrom, K., McDonald, J. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "683-686"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lefcort,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Venstrom,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "McDonald,"

Phrase: "J."
Processing 00000000.tx.556: A., and Reichardt, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Reichardt,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.557: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.558: (1992) Development (Camb.) 

Phrase: "(1992"

Phrase: ")"

Phrase: "Development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "(Camb."

Phrase: ")"
Processing 00000000.tx.559: 116, 767-82 Snow, A. 

Phrase: "116,"

Phrase: "767-82 Snow,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037386:Snow [Natural Phenomenon or Process]
   827   C1611690:Snow [Substance]

Phrase: "A."
Processing 00000000.tx.560: D., Mar, H., Nochlin, D., Kresse, H., and Wight, T. 

Phrase: "D."

Phrase: ","

Phrase: "Mar"

Phrase: ","

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nochlin,"

Phrase: "D."

Phrase: ","

Phrase: "Kresse,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wight,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.561: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.562: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.563: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.564: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.565: 40, 105-113 [Abstract/Free FullText] Perlmutter, L. 

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "105-113"

Phrase: "[Abstract/Free FullText"

Phrase: "] Perlmutter,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.566: S., Chui, H. 

Phrase: "S."

Phrase: ","

Phrase: "Chui,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.567: C., Saperia, D., and Athanikar, J. 

Phrase: "C., Saperia,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Athanikar,"

Phrase: "J."
Processing 00000000.tx.568: (1990) Brain Res. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.569: 508, 13-19 [Medline] [OrderarticleviaInfotrieve] Von der Kammer, H., Hanes, J., Klaudiny, J., and Scheit, K. 

Phrase: "508,"

Phrase: "13-19"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Von der Kammer,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hanes,"

Phrase: "J.,"

Phrase: "Klaudiny,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Scheit,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.570: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.571: (1994) DNA Cell Biol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "DNA Cell Biol."
Processing 00000000.tx.572: 13, 1137-1143 [Medline] [OrderarticleviaInfotrieve] Vidal, F., Blangy, A., Rassoulzadegan, M., and Cuzin, F. 

Phrase: "13,"

Phrase: "1137-1143"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vidal,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Blangy,"

Phrase: "A.,"

Phrase: "Rassoulzadegan,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Cuzin,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.573: (1992) Biochem. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.574: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.575: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.576: Commun. 

Phrase: "Commun."
Processing 00000000.tx.577: 189, 1336-1341 [Medline] [OrderarticleviaInfotrieve] Miller, E. 

Phrase: "189,"

Phrase: "1336-1341"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "E."
Processing 00000000.tx.578: J., Lane, J. 

Phrase: "J.,"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "J."
Processing 00000000.tx.579: M., and Piez, K. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Piez,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.580: A. 

Phrase: "A."
Processing 00000000.tx.581: (1969) Biochemistry 8, 30-39 [Medline] [OrderarticleviaInfotrieve] Piez, K. 

Phrase: "(1969"

Phrase: ")"

Phrase: "Biochemistry 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "30-39"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Piez,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.582: A., Miller, E. 

Phrase: "A.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "E."
Processing 00000000.tx.583: J., Lane, J. 

Phrase: "J.,"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "J."
Processing 00000000.tx.584: M., and Butler, W. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Butler,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402644:Butler [Professional or Occupational Group]

Phrase: "W."
Processing 00000000.tx.585: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.586: (1969) Biochem. 

Phrase: "(1969"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.587: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.588: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.589: Commun. 

Phrase: "Commun."
Processing 00000000.tx.590: 37, 801-805 [Medline] [OrderarticleviaInfotrieve] 1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "37,"

Phrase: "801-805"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 1996 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

